var title_f3_55_3952="Left atrial myxoma long axis";
var content_f3_55_3952=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/80469/laxmyxom_conv.mp4?title=Left+atrial+myxoma+long+axis\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left atrial myxoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Long axis view from a two-dimensional echocardiogram shows a large myxoma in the left atrium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Neil Weisman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3952=[""].join("\n");
var outline_f3_55_3952=null;
var title_f3_55_3953="Vertical mattress retention sutures";
var content_f3_55_3953=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F58213&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F58213&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vertical mattress retention sutures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 406px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3953=[""].join("\n");
var outline_f3_55_3953=null;
var title_f3_55_3954="Patient information: Care after weight loss surgery (The Basics)";
var content_f3_55_3954=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?14/31/14835\">",
"         Patient information: Weight loss surgery (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/37/9811\">",
"         Patient information: Weight loss surgery (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Care after weight loss surgery (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H86328271\">",
"      <span class=\"h1\">",
"       Will I need to change the way I eat after weight loss surgery?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. After your surgery, you can only drink liquids for the first week or so. You can then slowly start to eat solid foods. Work with a nutritionist (a food expert) to learn how your diet should change. If you eat the wrong things, you could hurt your chances of losing weight.",
"     </p>",
"     <p>",
"      You will need to:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Eat slowly and chew your food well.",
"       </li>",
"       <li>",
"        Stop eating when you feel full. You will feel full much sooner than before the surgery because your stomach is so much smaller.",
"       </li>",
"       <li>",
"        Eat healthy foods that are high in protein and low in fat and calories.",
"       </li>",
"       <li>",
"        Avoid drinking and eating at the same time. Wait 30 minutes after you finish eating to drink water or other beverages.",
"       </li>",
"       <li>",
"        Avoid sugary foods.",
"       </li>",
"       <li>",
"        Avoid liquid foods that are high in calories, such as ice cream.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You might find that you dislike foods that you used to like, such as meat. You might also find that you like foods that you used to dislike, such as fruits and vegetables.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H86328288\">",
"      <span class=\"h1\">",
"       Will I need to take vitamin and mineral supplements?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You will need to take special multivitamins with minerals. That's because weight loss surgery can make it hard for your body to get all the nutrients it needs. You must keep taking the vitamins for the rest of your life. Your body will always need them to stay healthy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H86328305\">",
"      <span class=\"h1\">",
"       How often will I need to see my doctor?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should see your doctor every 4 to 6 weeks for the first 6 months after your surgery, then every 3 months. After 1 year, you can switch to yearly visits. He or she will check your weight and blood pressure and make sure you do not have any problems caused by the surgery.",
"     </p>",
"     <p>",
"      You will also need blood tests to check that your body is getting all the nutrients you need to stay healthy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H86328322\">",
"      <span class=\"h1\">",
"       Will my health problems get better after weight loss surgery?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people who have weight loss surgery find that certain health problems get better or go away after they lose weight. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Diabetes",
"       </li>",
"       <li>",
"        High blood pressure",
"       </li>",
"       <li>",
"        High cholesterol",
"       </li>",
"       <li>",
"        Sleep apnea, a disorder that causes you to stop breathing for short amounts of time while you sleep",
"       </li>",
"       <li>",
"        Gastroesophageal reflux disease, a condition that causes heartburn",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Because of these changes, you might be able to cut back or stop taking medicines for these problems. But be sure to check with your doctor before changing how you take any of your medicines.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H86328339\">",
"      <span class=\"h1\">",
"       What health problems can happen after weight loss surgery?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Problems that can happen between 1 and 6 weeks after the surgery include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Bleeding",
"       </li>",
"       <li>",
"        Infection",
"       </li>",
"       <li>",
"        A blockage or tear in the intestines",
"       </li>",
"       <li>",
"        Problems with the heart or lungs",
"       </li>",
"       <li>",
"        The need for more surgery",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Problems that can happen between 7 and 12 weeks after surgery include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Vomiting &ndash; This can happen after gastric banding if you don&rsquo;t chew your food enough, take large bites, or eat too fast. If you had gastric bypass, sores or blockages in your intestines can cause this problem.",
"       </li>",
"       <li>",
"        Dumping syndrome &ndash; This happens if you had gastric bypass and eat sugary foods. It causes you to feel sick to your stomach, light-headed, and to shake, sweat, and turn red and feel hot, especially on your face. It can also cause loose bowel movements (diarrhea).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Problems that can happen 4 to 12 months after surgery include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Gallstones &ndash; These are small, sometimes painful stones that form inside the gallbladder, a small organ under the liver.",
"       </li>",
"       <li>",
"        A blockage in the intestines (called an &ldquo;obstruction&rdquo;)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you had gastric banding, the band can slip or wear down the tissue underneath the band, but this is rare.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H86328356\">",
"      <span class=\"h1\">",
"       How will I feel after I have weight loss surgery?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After losing large amounts of weight, you might feel more confident, successful, and able to talk about your feelings. But you might also feel sad or depressed. This can happen if you used to eat large amounts of food for comfort and can no longer do so.",
"     </p>",
"     <p>",
"      Because your eating habits are different, you might feel awkward at business or social events that focus on food. You might find that your relationships with family, friends, and coworkers change if they treat you differently as a thin person.",
"     </p>",
"     <p>",
"      You can ask your doctor to recommend a counselor (such as a social worker or therapist) or a support group to help you cope with the changes after weight loss surgery.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H86328373\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Women who are very overweight are more likely to get pregnant if they lose large amounts of weight. But you should not try to get pregnant for at least a year after weight loss surgery. To avoid pregnancy, you should not take birth control pills, because they might not work as well as usual in women who have had weight loss surgery.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H86328390\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/31/14835?source=see_link\">",
"       Patient information: Weight loss surgery (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/37/9811?source=see_link\">",
"       Patient information: Weight loss surgery (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?3/55/3954?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86218 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-C80C007BE0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3954=[""].join("\n");
var outline_f3_55_3954=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328271\">",
"      Will I need to change the way I eat after weight loss surgery?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328288\">",
"      Will I need to take vitamin and mineral supplements?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328305\">",
"      How often will I need to see my doctor?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328322\">",
"      Will my health problems get better after weight loss surgery?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328339\">",
"      What health problems can happen after weight loss surgery?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328356\">",
"      How will I feel after I have weight loss surgery?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328373\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86328390\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/37/9811?source=related_link\">",
"      Patient information: Weight loss surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/31/14835?source=related_link\">",
"      Patient information: Weight loss surgery (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_55_3955="VF congr incompl HH";
var content_f3_55_3955=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F77489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F77489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Visual fields: Congruous incomplete homonymous hemianopia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 400px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Humphrey visual field (24-2) showing a right congruous incomplete homonymous hemianopia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3955=[""].join("\n");
var outline_f3_55_3955=null;
var title_f3_55_3956="Tetrahydrozoline (nasal): Patient drug information";
var content_f3_55_3956=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tetrahydrozoline (nasal): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/18/24867?source=see_link\">",
"     see \"Tetrahydrozoline (nasal): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9600033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tyzine&reg;;",
"     </li>",
"     <li>",
"      Tyzine&reg; Pediatric",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691980",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703013",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tetrahydrozoline or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694774",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use in your nose only. Keep out of your mouth and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694567",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blow your nose before use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use if solution changes color.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12318 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-14B9D587E9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3956=[""].join("\n");
var outline_f3_55_3956=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600033\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024769\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024771\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024770\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024775\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024776\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024778\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024773\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024774\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024779\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024780\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/18/24867?source=related_link\">",
"      Tetrahydrozoline (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/21/19795?source=related_link\">",
"      Tetrahydrozoline (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/62/6116?source=related_link\">",
"      Tetrahydrozoline (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_55_3957="Contents: Children's health";
var content_f3_55_3957=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?18/22/18798\">",
"       Patient Information",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Children's health",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Children's health",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Asthma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/58/17315\">",
"           Patient information: Asthma in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/3/44083\">",
"           Patient information: Asthma inhaler techniques in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/60/18374\">",
"           Patient information: Asthma treatment in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/52/13122\">",
"           Patient information: How to use your child���������s dry powder inhaler (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33858\">",
"           Patient information: How to use your child���������s metered dose inhaler (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/43/30386\">",
"           Patient information: Inhalers (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Birth defects",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/43/41649\">",
"           Patient information: Aortic coarctation in adults (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/47/25329\">",
"           Patient information: Aortic coarctation in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/31/6642\">",
"           Patient information: Atrial septal defect (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/36/43585\">",
"           Patient information: Cleft lip and cleft palate (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/23/23921\">",
"           Patient information: Hypospadias (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/22/43361\">",
"           Patient information: Meckel���������s diverticulum (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/1/12306\">",
"           Patient information: Patent foramen ovale (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/15/13555\">",
"           Patient information: Spina bifida (myelomeningocele) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/25/2450\">",
"           Patient information: Tetralogy of Fallot (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/15/242\">",
"           Patient information: Total anomalous pulmonary venous connection in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/26/4514\">",
"           Patient information: Ventricular septal defect (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Blood disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/17/29970\">",
"           Patient information: Immune thrombocytopenia (ITP) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/8/4227\">",
"           Patient information: Sickle cell anemia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7394\">",
"           Patient information: Thalassemia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/12/22723\">",
"           Patient information: When your child has sickle cell disease (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Bones, joints, and muscles",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/51/22320\">",
"           Patient information: Back pain in children and adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/45/38609\">",
"           Patient information: Developmental dysplasia of the hip (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/61/12242\">",
"           Patient information: Juvenile rheumatoid arthritis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/7/17521\">",
"           Patient information: Kyphosis in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/4/34881\">",
"           Patient information: Nursemaid���������s elbow (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/6/7267\">",
"           Patient information: Psoriatic arthritis in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/20/18754\">",
"           Patient information: Scoliosis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/41/29329\">",
"           Patient information: Torticollis in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Brain, mind, and learning",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/18/24865\">",
"           Patient information: Asperger syndrome (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/32/11778\">",
"           Patient information: Attention deficit hyperactivity disorder (ADHD) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/37/38481\">",
"           Patient information: Autism (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/46/41699\">",
"           Patient information: Autism spectrum disorders (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/45/29394\">",
"           Patient information: Down syndrome (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/28/34242\">",
"           Patient information: Down syndrome (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/22/29025\">",
"           Patient information: Dyslexia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/4/12355\">",
"           Patient information: Fragile X syndrome (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/15/36086\">",
"           Patient information: Headache in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27090\">",
"           Patient information: Headaches in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/9/44177\">",
"           Patient information: Hydrocephalus (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/47/38641\">",
"           Patient information: Learning disabilities (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/42/3746\">",
"           Patient information: Medicines for attention deficit hyperactivity disorder (ADHD) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/9/33938\">",
"           Patient information: Migraine headaches in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/8/33922\">",
"           Patient information: Symptoms and diagnosis of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/53/35668\">",
"           Patient information: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Breastfeeding",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/25/17813\">",
"           Patient information: Breast pumps (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/22/36194\">",
"           Patient information: Breast pumps (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/43/17075\">",
"           Patient information: Breastfeeding (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/19/1333\">",
"           Patient information: Breastfeeding guide (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/61/37845\">",
"           Patient information: Common breastfeeding problems (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/26/3491\">",
"           Patient information: Common breastfeeding problems (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/63/34805\">",
"           Patient information: Deciding to breastfeed (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/19/38194\">",
"           Patient information: Deciding to breastfeed (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/13/7379\">",
"           Patient information: Health and nutrition for women who breastfeed (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/54/31588\">",
"           Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/0/25602\">",
"           Patient information: Weaning from breastfeeding (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/27/4531\">",
"           Patient information: Weaning from breastfeeding (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/50/31523\">",
"           Patient information: Hodgkin lymphoma in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/40/24194\">",
"           Patient information: Leukemia in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Care and feeding of infants",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/48/41729\">",
"           Patient information: Caring for an uncircumcised penis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/5/1107\">",
"           Patient information: Circumcision in baby boys (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/36/29249\">",
"           Patient information: Circumcision in baby boys (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/53/38738\">",
"           Patient information: Colic (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/7/1140\">",
"           Patient information: Colic (excessive crying) in infants (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/49/26386\">",
"           Patient information: Poor weight gain in babies and children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/18/8486\">",
"           Patient information: Poor weight gain in infants and children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/32/41476\">",
"           Patient information: Starting solid foods during infancy (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/59/7091\">",
"           Patient information: Starting solid foods with babies (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/40/7811\">",
"           Patient information: Sudden infant death syndrome (SIDS) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/38/38497\">",
"           Patient information: Sudden infant death syndrome (SIDS) (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cerebral palsy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/8/29825\">",
"           Patient information: Cerebral palsy (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diabetes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/52/37699\">",
"           Patient information: Carb counting and your child���������s diet (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39331\">",
"           Patient information: Checking your child���������s blood sugar level (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/2/36898\">",
"           Patient information: Diabetic ketoacidosis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/33/5651\">",
"           Patient information: Giving your child insulin (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/25/36243\">",
"           Patient information: Keeping your child���������s blood sugar under control (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/11/38066\">",
"           Patient information: Managing diabetes in school (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/48/18179\">",
"           Patient information: My child has diabetes: How will we manage? (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/43/692\">",
"           Patient information: Type 1 diabetes (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Digestive system",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/50/32547\">",
"           Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/11/40114\">",
"           Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/24/43394\">",
"           Patient information: Acid reflux (gastroesophageal reflux) in babies (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16643\">",
"           Patient information: Acid reflux (gastroesophageal reflux) in infants (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/37/3666\">",
"           Patient information: Appendicitis in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/14/11492\">",
"           Patient information: Celiac disease in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/55/29554\">",
"           Patient information: Crohn���������s disease in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/59/27570\">",
"           Patient information: Fecal incontinence in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/18/20770\">",
"           Patient information: Hirschsprung disease (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/33/34321\">",
"           Patient information: Intussusception (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/22/43361\">",
"           Patient information: Meckel���������s diverticulum (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/27/26033\">",
"           Patient information: Pyloric stenosis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/43/1714\">",
"           Patient information: Rectal prolapse in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/33/38418\">",
"           Patient information: Ulcerative colitis in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Down syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/45/29394\">",
"           Patient information: Down syndrome (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/28/34242\">",
"           Patient information: Down syndrome (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ear, nose, and throat",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/38/44642\">",
"           Patient information: Ear infections (otitis media) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/16/15619\">",
"           Patient information: Ear infections (otitis media) in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/9/20626\">",
"           Patient information: Ear tubes (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/50/1826\">",
"           Patient information: Nosebleeds (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/10/19617\">",
"           Patient information: Nosebleeds (epistaxis) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1634\">",
"           Patient information: Removing objects stuck up the nose (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/45/36561\">",
"           Patient information: Ruptured eardrum (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/19/34097\">",
"           Patient information: Screening for hearing loss in newborns (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/10/13475\">",
"           Patient information: Seasonal allergies in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/24/14722\">",
"           Patient information: Swallowed objects (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Eye infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/51/20274\">",
"           Patient information: Conjunctivitis (pinkeye) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/6/26721\">",
"           Patient information: Conjunctivitis (pinkeye) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/37/24145\">",
"           Patient information: Orbital cellulitis (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Eye problems",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/54/25441\">",
"           Patient information: Blocked tear duct (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/58/27553\">",
"           Patient information: Crossed eyes and lazy eye (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Flu",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/58/6050\">",
"           Patient information: Bird flu (avian influenza) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/47/33522\">",
"           Patient information: Flu (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/12/39105\">",
"           Patient information: Influenza prevention (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/12/35013\">",
"           Patient information: Influenza symptoms and treatment (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Food allergy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/27/35250\">",
"           Patient information: Food allergy (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/47/29429\">",
"           Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/35/35379\">",
"           Patient information: Food allergy treatment and avoidance (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/35/17971\">",
"           Patient information: Peanut allergy (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genetic conditions",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/57/20371\">",
"           Patient information: Cystic fibrosis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/30/5602\">",
"           Patient information: Familial hypercholesterolemia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/57/3986\">",
"           Patient information: Friedreich ataxia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/13/34001\">",
"           Patient information: Muscular dystrophy (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/41/26257\">",
"           Patient information: Neurofibromatosis type 1 (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/33/32276\">",
"           Patient information: Overview of muscular dystrophies (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Growth, puberty, and sexual health",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/8/35973\">",
"           Patient information: Adolescent sexuality (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/45/36562\">",
"           Patient information: Androgen replacement in men (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/56/19330\">",
"           Patient information: Congenital adrenal hyperplasia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/58/31650\">",
"           Patient information: Early puberty (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/31/13810\">",
"           Patient information: Late puberty (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/30/23010\">",
"           Patient information: My child is overweight (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/12/3266\">",
"           Patient information: My child is short (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/1/30738\">",
"           Patient information: Normal sexual development (puberty) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/21/1363\">",
"           Patient information: Teen sexuality (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/20/32065\">",
"           Patient information: Turner syndrome (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Heart and blood vessel disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/35/4660\">",
"           Patient information: Children and heart disease (atherosclerosis) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40835\">",
"           Patient information: Controlling your blood pressure through lifestyle (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/57/20369\">",
"           Patient information: Heart block in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"./henoch-schonlein-purpura-the-basics\">",
"           Patient information: Henoch-Sch������nlein purpura (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/28/38337\">",
"           Patient information: High blood pressure in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/37/30290\">",
"           Patient information: High blood pressure in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/58/931\">",
"           Patient information: High blood pressure treatment in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/24/36226\">",
"           Patient information: Hypertrophic cardiomyopathy in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/8/3201\">",
"           Patient information: Kawasaki disease (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hernias",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/44/42689\">",
"           Patient information: Groin (inguinal) hernias in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/57/27538\">",
"           Patient information: Chickenpox (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/40/2691\">",
"           Patient information: Chickenpox prevention and treatment (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/19/8498\">",
"           Patient information: Chronic granulomatous disease (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/5/13394\">",
"           Patient information: Erythema infectiosum (fifth disease) (The Basics )",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/60/24513\">",
"           Patient information: Hand, foot, and mouth disease (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/31/1522\">",
"           Patient information: Roseola (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/13/27858\">",
"           Patient information: Rotavirus infection (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/62/23521\">",
"           Patient information: Sepsis in newborn babies (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/59/43955\">",
"           Patient information: Swollen neck nodes in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/1/11282\">",
"           Patient information: Tonsillectomy and adenoidectomy in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Injuries, first aid, and CPR",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/50/26402\">",
"           Patient information: CPR for children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/47/8947\">",
"           Patient information: Closed head injury (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/12/22722\">",
"           Patient information: Concussion (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/35/20018\">",
"           Patient information: Elbow fracture in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/44/14020\">",
"           Patient information: Head injury in children and adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/45/40658\">",
"           Patient information: Head injury in children and adolescents (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/6/30819\">",
"           Patient information: Mouth and dental injuries in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/52/34626\">",
"           Patient information: Mouth and dental injuries in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/43/43697\">",
"           Patient information: Osgood-Schlatter disease (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/29/20945\">",
"           Patient information: Postconcussion syndrome (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/10/42145\">",
"           Patient information: Taking care of bruises (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/11/43185\">",
"           Patient information: Taking care of cuts and scrapes (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Kidneys and urinary system",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/9/1169\">",
"           Patient information: Blood in the urine (hematuria) in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/51/17202\">",
"           Patient information: Blood in the urine (hematuria) in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/2/21538\">",
"           Patient information: Daytime wetting (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/26/15779\">",
"           Patient information: Kidney stones in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/38/27234\">",
"           Patient information: Kidney stones in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/44/35523\">",
"           Patient information: Polycystic kidney disease (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/45/3794\">",
"           Patient information: Prenatal hydronephrosis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/58/38818\">",
"           Patient information: Urinary tract infections in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/38/10850\">",
"           Patient information: Urinary tract infections in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/19/38193\">",
"           Patient information: Vesicoureteral reflux in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Meningitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/35/16946\">",
"           Patient information: Aseptic meningitis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/1/31762\">",
"           Patient information: Bacterial meningitis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/6/36962\">",
"           Patient information: Fungal meningitis and septic arthritis outbreak (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/48/1796\">",
"           Patient information: Meningitis in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/43/3763\">",
"           Patient information: Meningitis in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/34/28194\">",
"           Patient information: Viral meningitis (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Mental health",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/6/13413\">",
"           Patient information: Depression in adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/21/29013\">",
"           Patient information: Depression treatment options for adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Movement disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/37/30289\">",
"           Patient information: Acute cerebellar ataxia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/57/3986\">",
"           Patient information: Friedreich ataxia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/47/17138\">",
"           Patient information: Multiple sclerosis in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Newborns",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/24/32129\">",
"           Patient information: Bronchopulmonary dysplasia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/5/1107\">",
"           Patient information: Circumcision in baby boys (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/36/29249\">",
"           Patient information: Circumcision in baby boys (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/6/2146\">",
"           Patient information: Congenital hernia of the diaphragm (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/34/27170\">",
"           Patient information: Congenital hypothyroidism (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/37/27217\">",
"           Patient information: Congenital syphilis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38529\">",
"           Patient information: Fetal alcohol syndrome (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/20/23873\">",
"           Patient information: Hemangioma (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/23/23921\">",
"           Patient information: Hypospadias (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/4/7233\">",
"           Patient information: Intraventricular hemorrhage in newborns (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/62/22498\">",
"           Patient information: Jaundice in babies (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/45/16083\">",
"           Patient information: Jaundice in newborn infants (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/31/31218\">",
"           Patient information: Newborn appearance (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/34/3618\">",
"           Patient information: Newborn conjunctivitis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/6/18529\">",
"           Patient information: Newborn hypoglycemia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/29/18897\">",
"           Patient information: Newborn necrotizing enterocolitis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/44/23233\">",
"           Patient information: Persistent pulmonary hypertension in a newborn (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/28/19905\">",
"           Patient information: Retinopathy of prematurity (ROP) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/19/34097\">",
"           Patient information: Screening for hearing loss in newborns (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/2/19490\">",
"           Patient information: Shoulder dystocia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/15/242\">",
"           Patient information: Total anomalous pulmonary venous connection in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/20/26945\">",
"           Patient information: Transient tachypnea of the newborn (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/58/43936\">",
"           Patient information: Undescended testes (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/62/8163\">",
"           Patient information: What to expect in the NICU (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/38/2659\">",
"           Patient information: When a baby is born premature (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nutrition",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/57/13202\">",
"           Patient information: Vitamin D for babies and children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Respiratory tract infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/10/39074\">",
"           Patient information: Bronchiolitis (and RSV) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/19/27958\">",
"           Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13427\">",
"           Patient information: Cough in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/55/18291\">",
"           Patient information: Cough, runny nose, and the common cold (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/63/32754\">",
"           Patient information: Croup (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/28/2500\">",
"           Patient information: Croup in infants and children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/44/14019\">",
"           Patient information: Mycoplasma pneumonia in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/17/14611\">",
"           Patient information: Pneumonia in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/59/40881\">",
"           Patient information: Scarlet fever (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/34/8738\">",
"           Patient information: Strep throat in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/44/40643\">",
"           Patient information: The common cold in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/38/36450\">",
"           Patient information: Whooping cough (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Safety",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/44/17089\">",
"           Patient information: Carbon monoxide (CO) poisoning (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/21/36179\">",
"           Patient information: Giving your child over-the-counter medicines (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/45/40658\">",
"           Patient information: Head injury in children and adolescents (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/40/22146\">",
"           Patient information: Lead poisoning (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/37/595\">",
"           Patient information: Secondhand smoke: Risks to children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Seizures and epilepsy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/0/18434\">",
"           Patient information: EEG (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/40/43650\">",
"           Patient information: Epilepsy in adults (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/54/38754\">",
"           Patient information: Epilepsy in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/35/39473\">",
"           Patient information: Febrile seizures (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/20/11586\">",
"           Patient information: Febrile seizures (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/26/419\">",
"           Patient information: Seizures in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19540\">",
"           Patient information: Treatment of seizures in children (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Skin, hair and nails",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/23/4466\">",
"           Patient information: Cellulitis and erysipelas (skin infections) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/38/32354\">",
"           Patient information: Contact dermatitis (including latex dermatitis) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/49/43793\">",
"           Patient information: Diaper rash (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/41/44690\">",
"           Patient information: Diaper rash in infants and children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/44/16065\">",
"           Patient information: Head lice (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/21/22865\">",
"           Patient information: Heat rash (prickly heat) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/5/43089\">",
"           Patient information: Lice (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/4/22595\">",
"           Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/47/31473\">",
"           Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/31/1522\">",
"           Patient information: Roseola (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/55/15217\">",
"           Patient information: Skin and soft tissue infection (cellulitis) (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sleep",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/9/17554\">",
"           Patient information: Night terrors, confusional arousals, and nightmares in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/28/36289\">",
"           Patient information: Sleepwalking in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Symptoms (diarrhea, sore throat, fever, etc.)",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/1/27\">",
"           Patient information: Acute diarrhea in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/11/10418\">",
"           Patient information: Bloody stools in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/40/29315\">",
"           Patient information: Chronic abdominal pain in children and adolescents (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/2/43041\">",
"           Patient information: Constipation in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/7/15477\">",
"           Patient information: Constipation in infants and children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13427\">",
"           Patient information: Cough in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/55/18291\">",
"           Patient information: Cough, runny nose, and the common cold (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/34/34338\">",
"           Patient information: Diarrhea in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/59/27570\">",
"           Patient information: Fecal incontinence in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/23/37235\">",
"           Patient information: Fever in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/40/40578\">",
"           Patient information: Fever in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/15/36086\">",
"           Patient information: Headache in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27090\">",
"           Patient information: Headaches in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/54/22371\">",
"           Patient information: Nausea and vomiting in infants and children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/22/3427\">",
"           Patient information: Sore throat in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/26/28066\">",
"           Patient information: Sore throat in children (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Toilet training and bedwetting",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/9/7315\">",
"           Patient information: Bedwetting in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/39/37489\">",
"           Patient information: Bedwetting in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/2/21538\">",
"           Patient information: Daytime wetting (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/59/27570\">",
"           Patient information: Fecal incontinence in children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/45/43730\">",
"           Patient information: Toilet training (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vaccines",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/57/27538\">",
"           Patient information: Chickenpox (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/40/2691\">",
"           Patient information: Chickenpox prevention and treatment (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/57/8082\">",
"           Patient information: Poliomyelitis (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/61/33746\">",
"           Patient information: Tdap vaccine (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/34/31266\">",
"           Patient information: Tetanus (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/22/28003\">",
"           Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/18/37156\">",
"           Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/7/18547\">",
"           Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/36/42566\">",
"           Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/38/36450\">",
"           Patient information: Whooping cough (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/42/18084\">",
"           Patient information: Why does my child need vaccines? (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-B85AB715CB-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f3_55_3957=[""].join("\n");
var outline_f3_55_3957=null;
var title_f3_55_3958="Benztropine: Drug information";
var content_f3_55_3958=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Benztropine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?38/44/39620?source=see_link\">",
"    see \"Benztropine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/45/36563?source=see_link\">",
"    see \"Benztropine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F140212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cogentin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F140213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Benztropine&reg;;",
"     </li>",
"     <li>",
"      Benztropine Omega;",
"     </li>",
"     <li>",
"      PMS-Benztropine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F140227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anti-Parkinson's Agent, Anticholinergic;",
"     </li>",
"     <li>",
"      Anticholinergic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F140216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute dystonia:",
"     </b>",
"     I.M., I.V.: 1-2 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Drug-induced extrapyramidal symptom:",
"     </b>",
"     Oral, I.M., I.V.: 1-4 mg 1-2 times/day or 1-2 mg 2-3 times/day for reactions developing soon after initiation of antipsychotic medication; usually provides relief within 1-2 days, but may continue for up to 1-2 weeks; withdraw after 1-2 weeks to reassess continued need for therapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Parkinsonism, idiopathic or postencephalitic:",
"     </b>",
"     Oral, I.M., I.V.: Usual dose: 1-2 mg/day; range: 0.5-6 mg/day in a single dose at bedtime or divided in 2-4 doses; titrate dose in 0.5 mg increments at 5- to 6-day intervals up to a maximum of 6 mg.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F140221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/45/36563?source=see_link\">",
"      see \"Benztropine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Drug-induced extrapyramidal symptoms:",
"     </b>",
"     Oral, I.M., I.V.: Children &gt;3 years (unlabeled dose): 0.02-0.05 mg/kg/dose 1-2 times/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F140217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Use caution or avoid; anticholinergics generally not tolerated in older adults.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682279\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F140194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as mesylate: 1 mg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cogentin&reg;: 1 mg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as mesylate: 0.5 mg, 1 mg, 2 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F140180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13244987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: May be given with or without food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injectable: May administer I.M or I.V. if oral route is unacceptable. Manufacturer&rsquo;s labeling states there is no difference in onset of effect after I.V. or I.M. injection and therefore there is usually no need to use the I.V. route. No specific instructions on administering benztropine I.V. are provided in the labeling. The I.V. route has been reported in the literature (slow I.V. push when reported), although specific instructions are lacking (Duncan, 2001; Lydon, 1998; Sachdev, 1993; Schramm, 2002).",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F140233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Fluconazole, tacrolimus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Chlorpromazine, fluphenazine, metoclopramide.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Haloperidol.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F140197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive treatment of Parkinson's disease; aid in the treatment of drug-induced extrapyramidal symptoms (except tardive dyskinesia)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F140235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Benztropine may be confused with bromocriptine",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Parkinson's disease:  Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F140225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Confusion, depression, disorientation, exacerbation of preexisting psychotic symptoms, fever, listlessness, memory impairment, nervousness, toxic psychosis, visual hallucinations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Heat stroke, hyperthermia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, nausea, paralytic ileus, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary retention, dysuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Numbness of fingers",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, mydriasis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F140200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to benztropine or any component of the formulation; children &lt;3 years of age",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F140184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anhidrosis/hyperthermia: May cause anhidrosis and hyperthermia, which may be severe; use with caution in hot weather or during exercise. The risk is increased in hot environments, particularly in the elderly, alcoholics, patients with CNS disease, and those with prolonged outdoor exposure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May be associated with confusion or hallucinations (generally at higher dosages); intensification of symptoms or toxic psychosis may occur in patients with mental disorders. May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Weakness: When given in large doses or to susceptible patients, may cause weakness and inability to move particular muscle groups.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with tachycardia, cardiac arrhythmias, hypertension, or hypotension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; GI obstruction: Use with caution in patients with obstructive disease of the GI tract (eg, pyloric or duodenal obstruction).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with glaucoma; avoid use in angle-closure glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mental disorders: Use with caution in patients with mental disorders and monitor closely; use may cause mental confusion and excitement, particularly in large doses. In the treatment of extrapyramidal disorders, an increase in mental symptoms may occur, potentially precipitating toxic psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Avoid use in patients with myasthenia gravis; may precipitate myasthenic crisis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture or retention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use of oral benztropine in older adults for prevention of extrapyramidal symptoms with antipsychotics and alternative agents preferred in the treatment of Parkinson's disease. May be inappropriate in older adults depending on comorbidities (eg, dementia, delirium) due to its potent anticholinergic effects  (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Use with caution in older children due to its anticholinergic effects; dose has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tardive dyskinesia: Not recommended for use in patients with tardive dyskinesia; benztropine does not relieve symptoms of tardive dyskinesia and may potentially exacerbate symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F140223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2D6 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F140189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ioflupane I 123: Benztropine may diminish the diagnostic effect of Ioflupane I 123.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F140210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: Avoid ethanol (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13276950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Paralytic ileus (which resolved rapidly) was reported in two newborns exposed to a combination of benztropine and chlorpromazine during the second and third trimesters and the last 6 weeks of pregnancy, respectively (Falterman, 1980).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F140219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13276951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if benztropine is excreted in breast milk. Anticholinergic agents may suppress lactation.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F13244991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tablet may be taken with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F140203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Benztropine Mesylate Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg/mL (2 mL): $66.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Cogentin Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg/mL (2 mL): $140.19",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Benztropine Mesylate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5 mg (100): $18.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg (100): $21.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg (100): $24.71",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F140192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptoms of EPS or Parkinson's, pulse, anticholinergic effects",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bentrop (AU, NZ);",
"     </li>",
"     <li>",
"      Cogentin (AT, AU, GB, HK, IE, MY, NZ, PT, SE, SG)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F140183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Possesses both anticholinergic and antihistaminic effects.",
"     <i>",
"      In vitro",
"     </i>",
"     anticholinergic activity approximates that of atropine;",
"     <i>",
"      in vivo",
"     </i>",
"     it is only about half as active as atropine. Animal data suggest its antihistaminic activity and duration of action approach that of pyrilamine maleate. May also inhibit the reuptake and storage of dopamine, thereby prolonging the action of dopamine.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F140199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: I.M., I.V.: Within a few minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic (N-oxidation, N-dealkylation, and ring hydroxylation) (from animal studies only)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: 7 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brocks DR, &ldquo;Anticholinergic Drugs Used in Parkinson&rsquo;s Disease: An Overlooked Class of Drugs from a Pharmacokinetic Perspective,&rdquo;",
"      <i>",
"       J Pharm Pharm Sci",
"      </i>",
"      , 1999, 2(2):39-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/10952768/pubmed\" id=\"10952768\" target=\"_blank\">",
"        10952768",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Duncan MA, Nikolov NM, and O&rsquo;Kelly B, &ldquo;Acute Chorea Due to Ondansetron in an Obstetric Patient,&rdquo;",
"      <i>",
"       Int J Obstet Anesth",
"      </i>",
"      , 2001, 10(4):309-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/15321589/pubmed\" id=\"15321589\" target=\"_blank\">",
"        15321589",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Feinberg M, &ldquo;The Problems of Anticholinergic Adverse Effects in Older Patients,&rdquo;",
"      <i>",
"       Drugs Aging",
"      </i>",
"      , 1993, 3(4):335-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/8369593/pubmed\" id=\"8369593\" target=\"_blank\">",
"        8369593",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Falterman CG and Richardson CJ, \"Small Left Colon Syndrome Associated With Maternal Ingestion of Psychotropic Drugs,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1980, 97(2):308-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/740090/pubmed\" id=\"740090\" target=\"_blank\">",
"        740090",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Harper G, Dawes M, Azlin C, et al, &ldquo;Small Bowel Obstruction in a Child on an Antipsychotic,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 1995, 5(1):81-4.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      He H, McKay G, and Midha KK, &ldquo;Phase I and II Metabolites of Benztropine in Rat Urine and Bile,&rdquo;",
"      <i>",
"       Xenobiotica",
"      </i>",
"      , 1995, 25(8):857-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/8779226/pubmed\" id=\"8779226\" target=\"_blank\">",
"        8779226",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lydon AM and Boylan JF, &ldquo;Reversibility of Parkinsonism-Induced Acute Upper Airway Obstruction by Benztropine Therapy,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1998, 87(4):975-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/9768805/pubmed\" id=\"9768805\" target=\"_blank\">",
"        9768805",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McEvoy JP, &ldquo;The Clinical Use of Anticholinergic Drugs as Treatment for Extrapyramidal Side Effects of Neuroleptic Drugs,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 1983, 3(5):288-302.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/6138370/pubmed\" id=\"6138370\" target=\"_blank\">",
"        6138370",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roth A, Akyol S, and Nelson JC, &ldquo;Delirium Associated With the Combination of a Neuroleptic, an SSRI, and Benztropine,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 1994, 55(11):492-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/7989283/pubmed\" id=\"7989283\" target=\"_blank\">",
"        7989283",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sachdev P and Loneragan C, &ldquo;Intravenous Benztropine and Propranolol Challenges in Tardive Akathisia,&rdquo;",
"      <i>",
"       Psychopharmacology (Berl)",
"      </i>",
"      , 1993, 113 (1):119-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/7862817/pubmed\" id=\"7862817\" target=\"_blank\">",
"        7862817",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schramm BM and Orser BA, &ldquo;Dystonic Reaction to Propofol Attenuated by Benztropine (Cogentin),&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2002, 94(5):1237-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/55/3958/abstract-text/11973196/pubmed\" id=\"11973196\" target=\"_blank\">",
"        11973196",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9106 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-DF5911362B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3958=[""].join("\n");
var outline_f3_55_3958=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140212\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140213\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140227\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140216\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140221\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140217\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682278\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682279\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140194\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140180\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13244987\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140233\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140197\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140235\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140225\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140200\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140184\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140223\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140189\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140210\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13276950\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140219\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13276951\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13244991\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140203\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140192\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038537\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140183\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140199\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9106\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9106|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?38/44/39620?source=related_link\">",
"      Benztropine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/45/36563?source=related_link\">",
"      Benztropine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_55_3959="Ulcerative lesion in blastomycosis";
var content_f3_55_3959=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Ulcerative perirectal lesion caused by Blastomyces dermatitidis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Extensive perirectal ulcerative lesion with overlying exudate in a patient who had disseminated blastomycosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Bradsher RW, Bariola JR. Blastomycosis. In: Essentials of Clinical Mycology, 2nd ed, Kauffman CA, Pappas PG, Sobel JD,&nbsp;Dismukes WE&nbsp;(Eds), Springer, New York City 2011; with kind permission from Springer Science + Business Media B.V. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3959=[""].join("\n");
var outline_f3_55_3959=null;
var title_f3_55_3960="Prevention of Lyme disease";
var content_f3_55_3960=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention of Lyme disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/55/3960/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3960/contributors\">",
"     Edward B Hayes, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3960/contributors\">",
"     Rebecca Eisen, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/55/3960/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3960/contributors\">",
"     Allen C Steere, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/55/3960/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3960/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/55/3960/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the discovery of the Lyme disease spirochete, Borrelia burgdorferi, in 1982, and the establishment of Lyme disease as a reportable disease in the United States in 1991, reported Lyme disease cases have increased so dramatically that it is now the most commonly reported vector-borne disease in the United States; over 20,000 cases are reported annually. Efforts to prevent Lyme disease have focused in four principal areas: personal protection, environmental intervention, prophylactic treatment, and vaccination.",
"   </p>",
"   <p>",
"    The effectiveness of any given preventive intervention is dependent on both the efficacy of the intervention and the level of engagement in the intervention by the target population [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/1\">",
"     1",
"    </a>",
"    ]. Thus, effective Lyme disease prevention depends on selection of strategies that are both efficacious and acceptable to people in endemic regions.",
"   </p>",
"   <p>",
"    Personal protection and environmental interventions for the prevention of Lyme disease and other tick-borne diseases will be reviewed here. The microbiology, epidemiology, clinical manifestations, diagnosis, and treatment of Lyme disease are discussed separately; the evaluation of a tick bite for possible Lyme disease, which includes a discussion of antibiotic prophylaxis, is also covered elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42342?source=see_link\">",
"     \"Microbiology of Lyme disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41431?source=see_link\">",
"     \"Epidemiology of Lyme disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=see_link\">",
"     \"Clinical manifestations of Lyme disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=see_link\">",
"     \"Lyme disease: Clinical manifestations in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28425?source=see_link\">",
"     \"Diagnosis of Lyme disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27498?source=see_link\">",
"     \"Treatment of Lyme disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26263?source=see_link\">",
"     \"Evaluation of a tick bite for possible Lyme disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PERSONAL PROTECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several strategies for personal protection against Lyme disease have been advocated (",
"    <a class=\"graphic graphic_figure graphicRef65153 \" href=\"UTD.htm?39/38/40547\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Checking for and removing ticks after outdoor activities",
"     </li>",
"     <li>",
"      Bathing after outdoor activities where ticks are abundant",
"     </li>",
"     <li>",
"      Wearing protective clothing",
"     </li>",
"     <li>",
"      Using tick repellent on skin and clothing",
"     </li>",
"     <li>",
"      Avoiding areas where ticks are abundant",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Checking for and removing ticks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on limited evidence of effectiveness, a theoretical basis for efficacy, and reasonable acceptability, we suggest tick checks and prompt tick removal following exposure to tick habitat. Methods for safely removing ticks are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26263?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation of a tick bite for possible Lyme disease\", section on 'Tick removal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is good experimental evidence that transmission of B. burgdorferi to mammalian hosts requires more than 48 hours of attachment of Ixodes scapularis ticks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26263?source=see_link&amp;anchor=H4#H4\">",
"     \"Evaluation of a tick bite for possible Lyme disease\", section on 'Tick attachment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies indicate that about 80 percent of residents of Lyme-endemic communities in Connecticut report checking themselves for ticks after outdoor activities [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Two case-control studies, which included 51 and 101 cases, respectively, suggested that tick checks might be effective in preventing Lyme disease, but the results were not statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. A subsequent study that included 364 cases and 349 matched controls showed a protective effect since cases were significantly less likely than controls to have performed tick checks within 36 hours of being outdoors (odds ratio 0.55, 95% CI 0.32-0.94) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/3\">",
"     3",
"    </a>",
"    ]. One other case-control study, including over 700 case patients and over 1000 controls, found that tick checks did not reduce the risk of Lyme disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/5\">",
"     5",
"    </a>",
"    ]. It is possible that reported tick checks in this study were not sufficiently thorough to detect the small nymphal ticks that transmit Lyme disease (",
"    <a class=\"graphic graphic_figure graphicRef68309 \" href=\"UTD.htm?39/6/40037\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H368486527\">",
"    <span class=\"h2\">",
"     Bathing after exposure to tick-infested habitat",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest bathing after exposure to tick habitat to reduce risk of Lyme disease. A case-control study conducted in Connecticut revealed that bathing within two hours of spending time in the yard was protective against Lyme disease (odds ratio 0.42, 95% CI 0.23-0.78) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/3\">",
"     3",
"    </a>",
"    ]. Although bathing is not expected to remove attached ticks, it could wash off ticks that have not yet attached, help enhance finding ticks on skin, and reduce exposure to ticks retained in clothing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Protective clothing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on limited evidence and a theoretical basis for efficacy, we suggest the use of long-legged and long-sleeved clothing that has been treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    or some similarly effective insecticide or repellent with low toxicity to humans to prevent Lyme disease among people who enter tick habitats in endemic areas.",
"   </p>",
"   <p>",
"    A case-control study, which included over 700 case patients and over 1000 controls, indicated that wearing protective clothing had an effectiveness of 40 percent in preventing Lyme disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/5\">",
"     5",
"    </a>",
"    ]. Another case-control study, which included 364 cases and 349 controls, did not show a significant difference between cases and controls in wearing long pants or light-colored clothing [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/3\">",
"     3",
"    </a>",
"    ]. In a study in which 10 volunteers walked in a tick-endemic area wearing either light or dark clothing, I. ricinus ticks seemed to be more attracted to light clothing than to dark clothing and the authors questioned whether ticks were more easily detected on light clothing [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/8\">",
"     8",
"    </a>",
"    ]. In a study of community behaviors, 60 percent of residents in three Connecticut communities reported always wearing long pants when in wooded or brushy areas, and 30 percent reported sometimes practicing these measures [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/4\">",
"     4",
"    </a>",
"    ]. The more intensive effort to tuck pants into socks does not seem as easy to adopt; only 10 to 40 percent of residents reported sometimes or always practicing this component [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two small studies have indicated that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    -impregnated clothing protects against tick bites [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], and one study has indicated that nootkatone-treated clothing repels ticks [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Tick repellents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Products containing DEET (N,N-diethyl-meta-toluamide) are effective tick repellents that can be applied to the skin and have been commercially available for many years.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     Permethrin",
"    </a>",
"    is an acaricide that can be applied to clothing to prevent tick bites. Other available tick repellents are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the theoretical basis for effectiveness, low risk of adverse events, and reasonable acceptability, we suggest the use of an efficacious tick repellent (eg, DEET) on skin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    on clothing for people who enter tick habitat. This strategy is likely to be most effective in individuals who apply repellents meticulously, but might be impractical and less acceptable for people who live in tick-infested areas and are regularly exposed to tick habitat.",
"   </p>",
"   <p>",
"    The effectiveness of tick repellents is probably most limited by lack of thoroughness of application. Estimates of the proportion of Connecticut residents who report using repellents outdoors range from 27 to 70 percent, but probably fewer than 30 percent consistently practice this strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. One case-control study found no effectiveness of repellent use in preventing Lyme disease, but the numbers of both cases and controls who used repellent were low [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/6\">",
"     6",
"    </a>",
"    ]. Another study showed a trend towards a reduction in risk of Lyme disease among individuals who wore repellent in the home yard, but the effect did not reach statistical significance (odds ratio 0.59, 95% CI 0.35-1.03) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/3\">",
"     3",
"    </a>",
"    ]. A larger study indicated that use of repellent had an effectiveness of 20 percent in preventing Lyme disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/5\">",
"     5",
"    </a>",
"    ]. The toxicities of DEET and other repellents are low when applied according to the manufacturer's directions and published guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A more detailed discussion of tick repellents, including safety profiles and recommendations for use in children and pregnant women, is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Avoiding tick habitat",
"    </span>",
"    &nbsp;&mdash;&nbsp;In three Connecticut communities where Lyme disease is endemic, more than 70 percent of residents reported avoiding wooded areas to attempt reducing their exposure to infected ticks [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/4\">",
"     4",
"    </a>",
"    ]. This strategy may be effective where isolated areas of high risk are focal and known, such as in Pacific coastal areas of North America and some areas of Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/14\">",
"     14",
"    </a>",
"    ]. However, in the northeastern United States tick habitat is often peridomestic, and residents may not be able to consistently avoid exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/2\">",
"     2",
"    </a>",
"    ]. In a northern California oak forest, researchers were more likely to acquire ticks when sitting on logs or gathering wood than when sitting on leaf litter, and tick densities were high on and around logs [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/15\">",
"     15",
"    </a>",
"    ]. Thus, some activities and microhabitats might present higher risk of tick exposure within larger areas of tick habitat.",
"   </p>",
"   <p>",
"    It seems prudent to recommend avoiding tick habitat when feasible, but such a recommendation is not likely to be practical or effective in highly-endemic areas where peridomestic tick exposure is common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Educational interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have assessed the effectiveness of educational programs to promote personal protection against Lyme disease, with mixed results.",
"   </p>",
"   <p>",
"    In one study, the effects of an educational program to prevent tick-borne illness were evaluated in 30,164 passengers on ferries bound for Nantucket Island [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/16\">",
"     16",
"    </a>",
"    ]. Boats were randomly assigned to either intervention or comparison educational programs. The intervention program promoted tick checks, avoidance of tick habitat, wearing protective clothing, repellent use, and early recognition of Lyme disease symptoms. The comparison program promoted prevention of bicycle and other road-related injuries. The occurrence of tick-borne illness was assessed through mailed questionnaires and, where possible, through follow-up with participant's healthcare providers. After the program, participants in the intervention group were more likely to report having checked themselves for ticks and taken precautions against tick bites. Reported occurrence of tick-borne illness was lower among intervention program participants who stayed on Nantucket for longer than two weeks compared with those who did not receive the tick education program (relative risk 0.41, 95% CI 0.18-0.95). No protective effect was seen among shorter-term visitors. Thus, it appears that this educational strategy was successful in promoting personal protective strategies against Lyme disease and at least partly successful in reducing the risk of tick-borne illness.",
"   </p>",
"   <p>",
"    In a smaller study, 317 residents of Baltimore County, Maryland, were randomly assigned to one of two mail-based educational programs. One group received mailings promoting use of repellents and early detection and removal of ticks, and the comparison group received mailings about health promotion not related to tick-borne diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/17\">",
"     17",
"    </a>",
"    ]. The intervention appeared successful at promoting tick checks and positive attitudes about repellent use, but there was no meaningful difference between the two groups in anti-recombinant tick calreticulin antibody levels, a biological marker for tick attachment of three or more days&rsquo; duration.",
"   </p>",
"   <p>",
"    A separate study described the outcomes of three community-based Lyme disease prevention programs (without control groups) in Connecticut [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/4\">",
"     4",
"    </a>",
"    ]. In two communities, the proportion of residents who reported checking themselves for ticks increased over the time period of the intervention, and in one of these communities the use of tick repellents also increased, but the use of other personal protective measures either decreased or remained unchanged. Two other studies have indicated that immigrant populations might require particular attention to promote knowledge about prevention and early treatment of Lyme disease, and one of these studies indicated that a clinic-based educational intervention was effective in increasing knowledge about Lyme disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ENVIRONMENTAL INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tick vectors of Lyme disease spirochetes spend part of their life cycle questing on vegetation to find hosts, a brief period of time feeding on hosts to obtain a blood meal, and a large part of their life span resting in leaf litter or soil. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41431?source=see_link\">",
"     \"Epidemiology of Lyme disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Environmental interventions aimed at reducing the number of infected nymphal I. scapularis ticks, which are the principal vectors of Lyme disease in eastern North America, can be separated into three main approaches: methods that target the tick directly, methods that target the tick or spirochete through the reservoir hosts, and landscape management to reduce human exposure to ticks (",
"    <a class=\"graphic graphic_figure graphicRef65153 \" href=\"UTD.htm?39/38/40547\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Targeting the tick",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditional methods for controlling ticks include the dispersion of pesticides that kill ticks (called acaricides) onto vegetation over a wide area. This approach to killing ticks has been shown to work quite well against the principal vectors of the Lyme disease spirochetes, Ixodes scapularis. Chemical acaricides such as carbaryl, cyfluthrin, or deltamethrin reduced the number of questing nymphal I. scapularis by 68 to 100 percent when applied to properties in Lyme disease-endemic regions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. In addition, a single well-timed application can be sufficient to reduce the population of questing ticks for most of the Lyme disease spirochete transmission season (mid-May through mid-July in the eastern United States). In one large case-control study in Connecticut, spraying of acaricides was not protective against Lyme disease, but the proportion of people who reported spraying was low (7 to 12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many residents of regions hyperendemic for Lyme disease in the eastern United States are reluctant to use chemical acaricides due to fears of environmental contamination and toxicity to family members and pets [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/5\">",
"     5",
"    </a>",
"    ]. Chemicals derived from botanical sources, so called \"natural products\", hold promise as both tick repellents and acaricides [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], and certain fungi (Metarhizium anisopliae) have also been demonstrated to kill ticks [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other biological agents, including parasitic wasps, nematodes, and predators (usually ants or beetles) have been shown to kill ticks [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/25\">",
"     25",
"    </a>",
"    ]. The main challenge for practical application of alternative tick control methods is to achieve commercial development of products that will be inexpensive, widely available, and accepted by both regulatory agencies and residents of affected communities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Targeting reservoir hosts",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three blood-feeding stages of I. scapularis: larva, nymph, and adult. In general, the immature stages (larva and nymph) feed on a variety of hosts including rodents, insectivores, birds, medium-sized mammals (eg, raccoons, skunks, and opossums), and deer. In contrast, the adults feed only on larger hosts, principally the white-tailed deer. These interactions make host-targeted approaches tempting as Lyme disease prevention strategies (",
"    <a class=\"graphic graphic_figure graphicRef65153 \" href=\"UTD.htm?39/38/40547\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41431?source=see_link\">",
"     \"Epidemiology of Lyme disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Rodents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first attempt at host-targeted intervention to prevent Lyme disease was to distribute cardboard tubes containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    -treated cotton balls, which were gathered as nesting material by white-footed mice. These mice, Peromyscus leucopus, are a principal reservoir host for B. burgdorferi. This approach worked quite well when initially tested on islands or in some coastal regions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/26,27\">",
"     26,27",
"    </a>",
"    ], but was not as effective in other locations [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/28\">",
"     28",
"    </a>",
"    ]. Variation in the importance of white-footed mice as reservoirs by geographic location may play a role in the differing effectiveness of this method observed in these studies.",
"   </p>",
"   <p>",
"    Another rodent-targeted intervention involves the use of bait boxes that attract a range of rodent reservoirs and treats them with an acaricide, fipronil, which is extremely long-lasting. This method reduced the number of nymphal I. scapularis infected with B. burgdorferi on an island off the coast of Connecticut [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/29\">",
"     29",
"    </a>",
"    ]. The utility of bait boxes on a large scale in various locations needs to be evaluated, and the boxes need to be resistant to destruction by squirrels, which cannot fit into the boxes to get the bait. Other potential rodent-targeted strategies in development include the use of oral outer surface protein A (OspA) vaccines for rodents [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/30\">",
"     30",
"    </a>",
"    ] and antibiotic-treated baits [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Deer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since adult I. scapularis feed almost exclusively on white-tailed deer, Odocoileus virginianus, acaricides could be applied directly to deer in order to kill ticks on the deer. A device developed by United States Department of Agriculture researchers that attracts deer to corn-loaded feeding stations and delivers acaricide to the deer via a series of paint rollers has been labeled the \"four-poster\" after the four paint rollers arrayed on the feeder [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/32\">",
"     32",
"    </a>",
"    ]. This device has been shown to decrease the populations of questing ticks in Lyme disease-endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is limited evidence from a small study that use of the four-poster device reduced the incidence of the erythema migrans rash of Lyme disease in an endemic community in Connecticut [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/34\">",
"     34",
"    </a>",
"    ]. A significant reduction in incidence was observed after implementation of the four-poster device compared with before implementation and in areas in which the four-poster device was used compared with control areas. However, the decrease was not statistically significant when the area in which the four-poster device was used was compared with an expanded control area, suggesting that the apparent effect might have been attributable to a general decreasing trend in Lyme disease incidence in both treatment and control areas. The acceptability of using the four-poster device has been partly limited by wildlife management concerns regarding the practice of baiting deer to feeding stations.",
"   </p>",
"   <p>",
"    Another approach involves removing the primary host for adult ticks from the Lyme disease-endemic region. On islands and semi-isolated coastal locations, complete eradication of deer virtually eliminated tick populations [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/35\">",
"     35",
"    </a>",
"    ]. The feasibility and effectiveness of deer elimination to reduce tick abundance has not been demonstrated in mainland communities. As an example, within a small community in Connecticut, a controlled deer hunt that reduced the estimated deer population by 92 percent did not lead to a significant reduction in Lyme disease incidence, despite a reduction in tick abundance, but the study&rsquo;s power to detect an effect on disease incidence was limited [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Integrated pest management",
"    </span>",
"    &nbsp;&mdash;&nbsp;An integrated approach to host-targeted tick control, called integrated pest management, has been tested in New Jersey utilizing bait boxes for attracting rodents in conjunction with four-posters for attracting deer [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/36\">",
"     36",
"    </a>",
"    ]. This method produced levels of tick control approaching 95 percent. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Rodents'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H12\">",
"     'Deer'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Landscape management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another approach involves landscape management to decrease the suitable habitat for ticks, thereby reducing human exposure to ticks (",
"    <a class=\"graphic graphic_figure graphicRef65153 \" href=\"UTD.htm?39/38/40547\">",
"     figure 1",
"    </a>",
"    ). An evaluation of the landscape ecology of tick populations in a suburban setting in New York State demonstrated that tick populations are distributed as follows by habitat (in descending order of density): forest, ecotone (the transition zone between two plant communities, as between forest and lawn), ornamental plantings, and lawn [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Human exposure to ticks can likely be reduced by placing outdoor recreational equipment such as swing sets away from the forest edge, and by laying down wood chips or gravel between woods and lawns to physically delimit the zones of high tick density. Attempts to alter vegetation to decrease tick habitat include mowing vegetation, removing leaf litter, and burning vegetation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Although these methods can be laborious, expensive, and must be sustained, they are generally readily accepted by the public and enthusiastically applied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PROPHYLAXIS FOR TICK BITE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic prophylaxis following a tick bite by an Ixodes tick is indicated in some cases. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26263?source=see_link&amp;anchor=H11674211#H11674211\">",
"     \"Evaluation of a tick bite for possible Lyme disease\", section on 'Antimicrobial prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     VACCINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A vaccine (Lymerix), consisting of an adjuvanted full-length copy of the B. burgdorferi outer surface protein (OspA), was approved in 1998 for the prevention of Lyme disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/40\">",
"     40",
"    </a>",
"    ]. Theoretical concerns were raised that the OspA antigen might increase the risk of autoimmune Lyme arthritis. However, there was no increase in the frequency of arthritis among individuals who received the OspA vaccine in clinical trials, and postmarketing surveillance indicated that the vaccine had a favorable safety profile [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/41-44\">",
"     41-44",
"    </a>",
"    ]. The manufacturer discontinued production of the vaccine due to poor sales and it is no longer available [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    New approaches to vaccine development are being explored, including the combination of multiple immunoprotective OspA epitopes in a single molecular formulation without the epitope that raised concern about autoimmune arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3960/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/40/30338?source=see_link\">",
"       \"Patient information: Lyme disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/0/27649?source=see_link\">",
"       \"Patient information: Lyme disease prevention (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/17/32022?source=see_link\">",
"       \"Patient information: Lyme disease symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/41/5778?source=see_link\">",
"       \"Patient information: Lyme disease treatment (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that individuals who enter tick habitat practice the following personal protective measures (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Use tick repellents, such as DEET, on skin and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"       permethrin",
"      </a>",
"      on clothing. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Tick repellents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wear insecticide- or repellent-treated, long-legged and long-sleeved clothing. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Protective clothing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Check for and promptly remove ticks after exposure to tick habitat. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Checking for and removing ticks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bathe after exposure to tick-infested areas, preferably within two hours after exposure. (See",
"      <a class=\"local\" href=\"#H368486527\">",
"       'Bathing after exposure to tick-infested habitat'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Area-wide dispersion of acaricides (pesticides that kill ticks) in Lyme disease-endemic regions can dramatically reduce tick populations. However, many residents of regions hyperendemic for Lyme disease in the eastern United States are reluctant to use chemical acaricides due to fears of environmental contamination and toxicity to family members and pets. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Targeting the tick'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Host-targeted tick control strategies, such as bait boxes containing acaricides for rodents or application of acaricides to kill ticks on deer, may be effective for reducing Lyme disease risk in certain settings. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Targeting reservoir hosts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Human exposure to ticks can likely be reduced by placing outdoor recreational equipment such as swing sets away from the forest edge, and by laying down wood chips or gravel between woods and lawns to delimit the zones of high tick density. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Landscape management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H605552812\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and editors at UpToDate would like to acknowledge Dr. Joseph Piesman, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/1\">",
"      Hayes EB, Maupin GO, Mount GA, Piesman J. Assessing the prevention effectiveness of local Lyme disease control. J Public Health Manag Pract 1999; 5:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/2\">",
"      Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med 2003; 348:2424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/3\">",
"      Connally NP, Durante AJ, Yousey-Hindes KM, et al. Peridomestic Lyme disease prevention: results of a population-based case-control study. Am J Prev Med 2009; 37:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/4\">",
"      Gould LH, Nelson RS, Griffith KS, et al. Knowledge, attitudes, and behaviors regarding Lyme disease prevention among Connecticut residents, 1999-2004. Vector Borne Zoonotic Dis 2008; 8:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/5\">",
"      V&aacute;zquez M, Muehlenbein C, Cartter M, et al. Effectiveness of personal protective measures to prevent Lyme disease. Emerg Infect Dis 2008; 14:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/6\">",
"      Orloski KA, Campbell GL, Genese CA, et al. Emergence of Lyme disease in Hunterdon County, New Jersey, 1993: a case-control study of risk factors and evaluation of reporting patterns. Am J Epidemiol 1998; 147:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/7\">",
"      Ley C, Olshen EM, Reingold AL. Case-control study of risk factors for incident Lyme disease in California. Am J Epidemiol 1995; 142:S39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/8\">",
"      Stjernberg L, Berglund J. Detecting ticks on light versus dark clothing. Scand J Infect Dis 2005; 37:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/9\">",
"      Miller NJ, Rainone EE, Dyer MC, et al. Tick bite protection with permethrin-treated summer-weight clothing. J Med Entomol 2011; 48:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/10\">",
"      Vaughn MF, Meshnick SR. Pilot study assessing the effectiveness of long-lasting permethrin-impregnated clothing for the prevention of tick bites. Vector Borne Zoonotic Dis 2011; 11:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/11\">",
"      Jordan RA, Schulze TL, Dolan MC. Efficacy of plant-derived and synthetic compounds on clothing as repellents against Ixodes scapularis and Amblyomma americanum (Acari: Ixodidae). J Med Entomol 2012; 49:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/12\">",
"      Katz TM, Miller JH, Hebert AA. Insect repellents: historical perspectives and new developments. J Am Acad Dermatol 2008; 58:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/13\">",
"      Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002; 347:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/14\">",
"      Piesman J, Eisen L. Prevention of tick-borne diseases. Annu Rev Entomol 2008; 53:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/15\">",
"      Lane RS, Steinlein DB, Mun J. Human behaviors elevating exposure to Ixodes pacificus (Acari: Ixodidae) nymphs and their associated bacterial zoonotic agents in a hardwood forest. J Med Entomol 2004; 41:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/16\">",
"      Daltroy LH, Phillips C, Lew R, et al. A controlled trial of a novel primary prevention program for Lyme disease and other tick-borne illnesses. Health Educ Behav 2007; 34:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/17\">",
"      Malouin R, Winch P, Leontsini E, et al. Longitudinal evaluation of an educational intervention for preventing tick bites in an area with endemic lyme disease in Baltimore County, Maryland. Am J Epidemiol 2003; 157:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/18\">",
"      Heller JE, Benito-Garcia E, Maher NE, et al. Behavioral and attitudes survey about Lyme disease among a Brazilian population in the endemic area of Martha's Vineyard, Massachusetts. J Immigr Minor Health 2010; 12:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/19\">",
"      Jenks NP, Trapasso J. Lyme risk for immigrants to the United States: the role of an educational tool. J Travel Med 2005; 12:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/20\">",
"      Curran KL, Fish D, Piesman J. Reduction of nymphal Ixodes dammini (Acari: Ixodidae) in a residential suburban landscape by area application of insecticides. J Med Entomol 1993; 30:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/21\">",
"      Schulze TL, Jordan RA, Hung RW, et al. Efficacy of granular deltamethrin against Ixodes scapularis and Amblyomma americanum (Acari: Ixodidade) nymphs. J Med Entomol 2001; 38:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/22\">",
"      Panella NA, Dolan MC, Karchesy JJ, et al. Use of novel compounds for pest control: insecticidal and acaricidal activity of essential oil components from heartwood of Alaska yellow cedar. J Med Entomol 2005; 42:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/23\">",
"      Dietrich G, Dolan MC, Peralta-Cruz J, et al. Repellent activity of fractioned compounds from Chamaecyparis nootkatensis essential oil against nymphal Ixodes scapularis (Acari: Ixodidae). J Med Entomol 2006; 43:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/24\">",
"      Benjamin MA, Zhioua E, Ostfeld RS. Laboratory and field evaluation of the entomopathogenic fungus Metarhizium anisopliae (Deuteromycetes) for controlling questing adult Ixodes scapularis (Acari: Ixodidae). J Med Entomol 2002; 39:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/25\">",
"      Samish M, Ginsberg H, Glazer I. Biological control of ticks. Parasitology 2004; 129 Suppl:S389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/26\">",
"      Mather TN, Ribeiro JM, Spielman A. Lyme disease and babesiosis: acaricide focused on potentially infected ticks. Am J Trop Med Hyg 1987; 36:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/27\">",
"      Deblinger RD, Rimmer DW. Efficacy of a permethrin-based acaricide to reduce the abundance of Ixodes dammini (Acari: Ixodidae). J Med Entomol 1991; 28:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/28\">",
"      Daniels TJ, Fish D, Falco RC. Evaluation of host-targeted acaricide for reducing risk of Lyme disease in southern New York state. J Med Entomol 1991; 28:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/29\">",
"      Dolan MC, Maupin GO, Schneider BS, et al. Control of immature Ixodes scapularis (Acari: Ixodidae) on rodent reservoirs of Borrelia burgdorferi in a residential community of southeastern Connecticut. J Med Entomol 2004; 41:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/30\">",
"      Gomes-Solecki MJ, Brisson DR, Dattwyler RJ. Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait. Vaccine 2006; 24:4440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/31\">",
"      Dolan MC, Schulze TL, Jordan RA, et al. Elimination of Borrelia burgdorferi and Anaplasma phagocytophilum in rodent reservoirs and Ixodes scapularis ticks using a doxycycline hyclate-laden bait. Am J Trop Med Hyg 2011; 85:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/32\">",
"      Pound JM, Miller JA, George JE, Lemeilleur CA. The '4-poster' passive topical treatment device to apply acaricide for controlling ticks (Acari: Ixodidae) feeding on white-tailed deer. J Med Entomol 2000; 37:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/33\">",
"      Carroll JF, Allen PC, Hill DE, et al. Control of Ixodes scapularis and Amblyomma americanum through use of the '4-poster' treatment device on deer in Maryland. Exp Appl Acarol 2002; 28:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/34\">",
"      Garnett JM, Connally NP, Stafford KC 3rd, Cartter ML. Evaluation of deer-targeted interventions on Lyme disease incidence in Connecticut. Public Health Rep 2011; 126:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/35\">",
"      Rand PW, Lubelczyk C, Holman MS, et al. Abundance of Ixodes scapularis (Acari: Ixodidae) after the complete removal of deer from an isolated offshore island, endemic for Lyme Disease. J Med Entomol 2004; 41:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/36\">",
"      Schulze TL, Jordan RA, Schulze CJ, et al. Integrated use of 4-Poster passive topical treatment devices for deer, targeted acaricide applications, and Maxforce TMS bait boxes to rapidly suppress populations of Ixodes scapularis (Acari: Ixodidae) in a residential landscape. J Med Entomol 2007; 44:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/37\">",
"      Maupin GO, Fish D, Zultowsky J, et al. Landscape ecology of Lyme disease in a residential area of Westchester County, New York. Am J Epidemiol 1991; 133:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/38\">",
"      Schulze TL, Jordan RA, Hung RW. Suppression of subadult Ixodes scapularis (Acari: Ixodidae) following removal of leaf litter. J Med Entomol 1995; 32:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/39\">",
"      Mather TN, Duffy DC, Campbell SR. An unexpected result from burning vegetation to reduce Lyme disease transmission risks. J Med Entomol 1993; 30:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/40\">",
"      Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 1998; 339:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/41\">",
"      Lathrop SL, Ball R, Haber P, et al. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine 2002; 20:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/42\">",
"      Poland GA. Vaccines against Lyme disease: What happened and what lessons can we learn? Clin Infect Dis 2011; 52 Suppl 3:s253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/43\">",
"      Shen AK, Mead PS, Beard CB. The Lyme disease vaccine--a public health perspective. Clin Infect Dis 2011; 52 Suppl 3:s247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/44\">",
"      Steere AC, Drouin EE, Glickstein LJ. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Clin Infect Dis 2011; 52 Suppl 3:s259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3960/abstract/45\">",
"      Livey I, O'Rourke M, Traweger A, et al. A new approach to a Lyme disease vaccine. Clin Infect Dis 2011; 52 Suppl 3:s266.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7895 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-BD1901CB76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3960=[""].join("\n");
var outline_f3_55_3960=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PERSONAL PROTECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Checking for and removing ticks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H368486527\">",
"      Bathing after exposure to tick-infested habitat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Protective clothing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Tick repellents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Avoiding tick habitat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Educational interventions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ENVIRONMENTAL INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Targeting the tick",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Targeting reservoir hosts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Rodents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Deer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Integrated pest management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Landscape management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PROPHYLAXIS FOR TICK BITE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      VACCINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H605552812\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7895\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7895|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/38/40547\" title=\"figure 1\">",
"      Lyme transmission cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/6/40037\" title=\"figure 2\">",
"      Tick sizes and appearances",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=related_link\">",
"      Clinical manifestations of Lyme disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28425?source=related_link\">",
"      Diagnosis of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41431?source=related_link\">",
"      Epidemiology of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26263?source=related_link\">",
"      Evaluation of a tick bite for possible Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=related_link\">",
"      Lyme disease: Clinical manifestations in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42342?source=related_link\">",
"      Microbiology of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/40/30338?source=related_link\">",
"      Patient information: Lyme disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/0/27649?source=related_link\">",
"      Patient information: Lyme disease prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/17/32022?source=related_link\">",
"      Patient information: Lyme disease symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/41/5778?source=related_link\">",
"      Patient information: Lyme disease treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=related_link\">",
"      Prevention of arthropod and insect bites: Repellents and other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27498?source=related_link\">",
"      Treatment of Lyme disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_55_3961="Lichen planus - oral Wickham striae";
var content_f3_55_3961=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F76338%7EDERM%2F62826%7EDERM%2F54143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F76338%7EDERM%2F62826%7EDERM%2F54143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral lichen planus - Wickham's striae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lacy white plaques (Wickham's striae) are present on the buccal mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erosive oral lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcers are present on the tongue in this patient with erosive oral lichen planus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema and erosions on the gingiva in a patient with oral lichen planus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3961=[""].join("\n");
var outline_f3_55_3961=null;
var title_f3_55_3962="Use of diuretics in patients with heart failure";
var content_f3_55_3962=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Use of diuretics in patients with heart failure",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/55/3962/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3962/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3962/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/55/3962/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3962/contributors\">",
"     Stephen S Gottlieb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/55/3962/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/55/3962/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/55/3962/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation and optimization of volume status is an essential component of treatment in patients with systolic or diastolic heart failure (HF) (",
"    <a class=\"graphic graphic_table graphicRef81590 graphicRef70468 \" href=\"UTD.htm?21/29/21982\">",
"     table 1A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"     1",
"    </a>",
"    ]. Removal of excess extracellular fluid with diuretics to treat peripheral",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary edema is one of the mainstays of volume management. In contrast to other HF therapies such as angiotensin inhibitors, beta blockers, and aldosterone antagonists, limited outcomes data are available for diuretic therapy.",
"   </p>",
"   <p>",
"    Issues related to the use of diuretics in patients with HF will be reviewed here. The evaluation, including assessment of volume status, and overall management of HF are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link\">",
"     \"Evaluation of the patient with suspected heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7544?source=see_link\">",
"     \"Evaluation of acute decompensated heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7018?source=see_link\">",
"     \"Treatment and prognosis of diastolic heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41079?source=see_link\">",
"     \"Treatment of acute decompensated heart failure: General considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31397796\">",
"    <span class=\"h1\">",
"     EFFICACY AND SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diuretics are the cornerstone of treatment of volume overload in patients with HF. However few clinical trials have studied the impact of diuretic therapy on clinical outcomes.",
"   </p>",
"   <p>",
"    A meta-analysis of diuretic treatment in chronic HF demonstrated a beneficial effect on clinical outcomes although only small trials were available [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/2\">",
"     2",
"    </a>",
"    ]. Three trials with a total of 202 patients with chronic HF found that a reduction in mortality with diuretic use compared to placebo (OR 0.24, 95% CI 0.07 to 0.83). Admission for worsening HF was reduced by diuretics compared to placebo in two trials with a total of 169 patients (OR 0.07, 95% CI 0.01 to 0.52). These results are consistent with data from observational studies as well as diuretic trials demonstrating rapid improvement in dyspnea in patients treated largely with diuretic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, observational data have raised safety concerns about diuretic treatment of HF. Several uncontrolled studies have found that higher diuretic doses are associated with worse outcomes, including mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/4\">",
"     4",
"    </a>",
"    ]. Use of nonpotassium sparing diuretics to treat HF has been associated with arrhythmic death [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/5\">",
"     5",
"    </a>",
"    ]. However, these observations are confounded by the indications for high dose diuretic use (ie, the need for higher doses of loop diuretics is likely a marker of more severe HF with increased mortality risk).",
"   </p>",
"   <p>",
"    The blood urea nitrogen (BUN) and serum creatinine often rise during diuretic treatment of HF and careful monitoring of renal function and electrolytes is recommended. These issues are discussed below. (See",
"    <a class=\"local\" href=\"#H16979970\">",
"     'Effects on renal function'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major issues that should be considered about diuretic therapy in patients with HF include salt and water restriction, the choice and dose of diuretic, hemodynamic consequences of the diuresis, improved survival with aldosterone antagonism, and variable effects on systemic vascular resistance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1507026889\">",
"    <span class=\"h2\">",
"     Salt and water restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important determinant of the efficacy of diuretic therapy is restriction of salt intake, which is likely to be easier to achieve in the hospital than in the outpatient setting. The 2010 Heart Failure Society of America (HFSA) guidelines on ADHF recommend a sodium intake of less than 2",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    and consideration of even greater sodium restriction in patients with recurrent or refractory volume overload [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Water restriction may also be important. Hyponatremia, a marker of excess water in relation to sodium, is common in patients with HF and the degree of hyponatremia parallels the severity of the HF. The HFSA guidelines recommend fluid restriction of less than 2",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    if the serum sodium is less than 130",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    and, if tolerated by the patient, greater fluid restriction if the serum sodium is less than 125",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    or is falling [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/6\">",
"     6",
"    </a>",
"    ]. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38742?source=see_link&amp;anchor=H3#H3\">",
"     \"Hyponatremia in patients with heart failure\", section on 'Predictor of adverse prognosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38742?source=see_link&amp;anchor=H5#H5\">",
"     \"Hyponatremia in patients with heart failure\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Diuretic use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with HF and volume overload are initially treated with the combination of an oral loop diuretic (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"     torsemide",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"     bumetanide",
"    </a>",
"    ) and a low sodium diet. The three major manifestations of volume overload in HF are pulmonary congestion, peripheral edema, and elevated jugular venous pressure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link&amp;anchor=H7#H7\">",
"     \"Evaluation of the patient with suspected heart failure\", section on 'Volume assessment'",
"    </a>",
"    .) Intravenous administration of loop diuretics (either as a bolus or a continuous infusion) is generally required for acute decompensation or severe disease. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Refractory edema'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Loop diuretics are often required for fluid control and to relieve symptoms, but the risk of arrhythmic death may be increased if hypokalemia occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/5\">",
"     5",
"    </a>",
"    ]. However, the data supporting this observation may be confounded by the fact that the need for loop diuretics may be correlated with more severe HF and increased mortality risk.",
"   </p>",
"   <p>",
"    Aldosterone antagonism with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"     eplerenone",
"    </a>",
"    can be added to loop diuretics to modestly enhance the diuresis and minimize potassium loss. More importantly, these drugs improve survival in patients with systolic HF. Eplerenone is a more specific aldosterone antagonist that is associated with fewer side effects but is much more expensive. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=see_link\">",
"     \"Use of aldosterone antagonists in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonsteroidal antiinflammatory agents (NSAIDs) are among the drugs that should be",
"    <strong>",
"     avoided",
"    </strong>",
"    in patients with HF, in part because they interfere with the response to diuretics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/3/42039?source=see_link&amp;anchor=H4#H4\">",
"     \"Drugs that should be avoided or used with caution in patients with heart failure\", section on 'Nonsteroidal antiinflammatory drugs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/4/24648?source=see_link&amp;anchor=H7#H7\">",
"     \"Nonselective NSAIDs: Adverse cardiovascular effects\", section on 'Heart failure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9160724\">",
"    <span class=\"h2\">",
"     Use of loop diuretics",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9160774\">",
"    <span class=\"h3\">",
"     Choice of loop diuretic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data are available on the comparative efficacy of various loop diuretics in HF.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     Furosemide",
"    </a>",
"    is the most commonly used loop diuretic in patients with HF. However oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"     torsemide",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"     bumetanide",
"    </a>",
"    may be preferred to oral furosemide in certain circumstances. The bioavailability of oral furosemide is only about 50 percent overall with substantial",
"    <strong>",
"     interpatient and intrapatient variability",
"    </strong>",
"    (range 10 to 100 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. As a result, there may be a greater response to oral torsemide or bumetanide, which are more predictably absorbed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. In addition, torsemide has a longer half-life than both furosemide and bumetanide.",
"   </p>",
"   <p>",
"    A potential benefit of oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"     torsemide",
"    </a>",
"    over",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    was suggested by the following two studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An open label, randomized trial enrolled 234 patients with chronic HF who were treated with either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      at average daily doses of 136 and 72 mg, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/9\">",
"       9",
"      </a>",
"      ]. The primary endpoint of readmission for HF at one year was significantly lower with torsemide (17 versus 32 percent). If using torsemide reduces the risk of hospitalization, it may be a cost-effective treatment despite its higher per dose cost [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An observational post-marketing surveillance study of 1377 patients with NYHA class II to III HF (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"       table 2",
"      </a>",
"      ) found a significantly lower one-year mortality among those receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      compared with those receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      or other diuretics (2.2 versus 4.5 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data are more limited on the relative efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"     bumetanide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We generally start diuretic therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    but switch to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"     torsemide",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"     bumetanide",
"    </a>",
"    if the response to furosemide is inadequate. However, an alternative strategy is to give high doses of oral furosemide, adjusting the dose to the patient&rsquo;s diuretic response as determined by daily weights. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Loop diuretic dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to appropriate dosing of loop diuretics in patients with HF and the treatment of refractory edema are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/48/40710?source=see_link\">",
"     \"Loop diuretics: Maximum effective dose and major side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link\">",
"     \"Treatment of refractory edema in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Loop diuretics are associated with a classic dose-response curve between the rate of diuretic excretion and the natriuresis (",
"      <a class=\"graphic graphic_figure graphicRef67654 \" href=\"UTD.htm?16/36/16973\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/14\">",
"       14",
"      </a>",
"      ]. Patients with HF have a lesser response to a given dose than normal subjects for two reasons: decreased diuretic delivery to the kidney because renal blood flow is reduced; and increased sodium reabsorption at other sites due to hypoperfusion-induced activation of the renin-angiotensin-aldosterone and sympathetic nervous systems. Although intestinal absorption of an oral loop diuretic may be delayed in patients with edema [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/14\">",
"       14",
"      </a>",
"      ], the total amount of drug absorbed is the same as in healthy individuals and the clinical implications of slowed absorption in patients with chronic heart failure are unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32455?source=see_link\">",
"       \"Pathophysiology of heart failure: Neurohumoral adaptations\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An effective diuretic dose must be determined. The usual starting dose is 20 to 40 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      or its equivalent. Subsequent dosing is determined by the diuretic response. Thus, if a patient does not respond to 20 mg of furosemide, the dose should be increased to 40 mg rather than giving the same dose twice a day. Maximum single doses are discussed below. (See",
"      <a class=\"local\" href=\"#H9160965\">",
"       'Treatment of ADHF'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H4327964\">",
"       'Chronic therapy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      If the patient is already receiving the maximum loop diuretic dose and has a partial but inadequate diuresis, the loop diuretic can be given twice or even three times a day.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9160965\">",
"    <span class=\"h4\">",
"     Treatment of ADHF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acute decompensated heart failure (ADHF) and evidence of fluid overload should be treated with intravenous diuretics as part of the initial therapeutic regimen. As noted in the 2009 focused update of the 2005 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association HF guidelines, diuretic therapy in patients with ADHF should be administered without delay in the emergency department or outpatient clinic since early intervention may produce better outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"     1",
"    </a>",
"    ]. Intravenous diuretics (either as a bolus or a continuous infusion) are more potent than equivalent oral doses, and elicit an earlier diuretic response, especially in the presence of significant interstitial edema in the gastrointestinal tract. The overall treatment of ADHF is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41079?source=see_link\">",
"     \"Treatment of acute decompensated heart failure: General considerations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34698?source=see_link\">",
"     \"Treatment of acute decompensated heart failure: Components of therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With intravenous therapy in patients with ADHF, the onset of diuresis is within 30 minutes with peak diuresis usually at one to two hours. Most patients require continued diuretic therapy after the initial dose. This can be achieved with the administration of two or more doses per day or with a continuous intravenous infusion.",
"   </p>",
"   <p>",
"    With these considerations in mind, the approach to initial diuretic therapy in patients with ADHF and fluid overload varies according to whether or not the patient has received prior loop diuretic therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with evidence of fluid overload who have",
"      <strong>",
"       not",
"      </strong>",
"      received prior loop diuretic therapy:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The usual initial intravenous bolus dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      is 20 to 40 mg. If there is little or no response the dose should be doubled at two hour intervals as needed up to the maximum recommended doses. In patients with a relatively normal glomerular filtration rate (typically estimated from the serum creatinine concentration), the maximum intravenous doses are usually 40 to 80 mg of furosemide, 20 to 40 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      , or 1 to 2 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      . However, patients with renal insufficiency may require higher maximum bolus doses of up to 160 to 200 mg of furosemide, 100 to 200 mg of torsemide, or 4 to 8 mg of bumetanide [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link&amp;anchor=H3#H3\">",
"       \"Treatment of refractory edema in adults\", section on 'Basic principles of diuretic dosing'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link&amp;anchor=H12#H12\">",
"       \"Treatment of refractory edema in adults\", section on 'Maximum effective dose of loop diuretics'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      A continuous intravenous infusion is an alternative to intravenous bolus therapy that may reduce the risk of ototoxicity associated with bolus doses. Use of a continuous intravenous infusion requires that the patient be responsive to intravenous bolus therapy, which results in higher initial plasma concentrations and therefore higher initial rates of urinary diuretic excretion than a continuous infusion. A continuous infusion should",
"      <strong>",
"       not",
"      </strong>",
"      be tried in patients who have not shown response to a maximum intravenous bolus dose. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link&amp;anchor=H19940053#H19940053\">",
"       \"Treatment of refractory edema in adults\", section on 'Regimen'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      As an example, an initial intravenous bolus of 20 to 40 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      administered over one to two minutes may be followed by a continuous infusion of approximately 5",
"      <span class=\"nowrap\">",
"       mg/h",
"      </span>",
"      in patients with relative intact renal function (estimated glomerular filtration rate greater than 75",
"      <span class=\"nowrap\">",
"       mL/min)",
"      </span>",
"      and rates of up to 20",
"      <span class=\"nowrap\">",
"       mg/h",
"      </span>",
"      in patients with an estimated glomerular filtration rate less than 30",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"      Adding a thiazide diuretic may potentiate the effect, but hypokalemia should be avoided. [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with evidence of fluid overload who",
"      <strong>",
"       have",
"      </strong>",
"      been taking a loop diuretic, the initial intravenous dose is generally equal to or greater than (eg, 2.5 times) the patient&rsquo;s chronic oral dose. In the DOSE trial of intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      in patients with ADHF, there was an almost significant trend toward greater improvement in patients&rsquo; global assessment of symptoms in the high-dose group (2.5 times the previous oral dose) compared to the low-dose group (equal to the patient&rsquo;s prior oral dose) as discussed below [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/3\">",
"       3",
"      </a>",
"      ]. Subsequent dose escalation and maximum doses are similar to those used in patients who are not already being treated with loop diuretics.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No single intravenous dosing regimen (bolus versus continuous infusion; high dose versus lower dose) has been shown to be superior to others as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of seven trials with a total of 221 patients with ADHF suggested that continuous infusion of a loop diuretic slightly increased the urine output (by a mean of 271",
"      <span class=\"nowrap\">",
"       mL/day)",
"      </span>",
"      compared to intermittent bolus injections [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/16\">",
"       16",
"      </a>",
"      ]. However, the studies were small and heterogeneous and the results were largely driven by the largest trial (107 patients) in which hypertonic saline was administered only to the patients receiving continuous infusion of diuretic.",
"     </li>",
"     <li>",
"      The best data come from the DOSE trial, published after the meta-analysis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/3\">",
"       3",
"      </a>",
"      ]. The trial randomly assigned 308 patients to receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      administered intravenously via either a bolus every 12 hours or continuous infusion and at either a low dose (equivalent to the patient&rsquo;s previous oral dose) or a high dose (2.5 times the previous oral dose). The efficacy endpoint was the patients&rsquo; global assessment of symptoms over the course of 72 hours and the safety endpoint was change in serum creatinine from baseline to 72 hours. Worsening renal function was defined as increase in the serum creatinine &gt;0.3",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [&gt;26.5",
"      <span class=\"nowrap\">",
"       micromol/L]",
"      </span>",
"      at any time during the 72 hours after randomization.",
"      <br/>",
"      <br/>",
"      The following findings were noted:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There was no significant difference in efficacy or safety endpoints for bolus versus continuous infusion. Patients assigned to intravenous bolus therapy were more likely to require a dose increase at 48 hours; as a result, the total dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      over 72 hours was higher in the bolus group compared with the continuous infusion group, a difference that was almost statistically different (592 versus 480 mg, P=0.06).",
"     </li>",
"     <li>",
"      High-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      , compared with low-dose furosemide, produced greater net fluid loss, weight loss, and relief from dyspnea but also more frequent transient worsening of renal function (23 versus 14 percent). There was an almost significant trend toward greater improvement in patients&rsquo; global assessment of symptoms in the high-dose group (P=0.06); the mean change in the serum creatinine was less than 0.1",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (9",
"      <span class=\"nowrap\">",
"       micromol/L)",
"      </span>",
"      in both groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, the available data suggest that intravenous continuous infusion and bolus loop diuretic therapy have similar efficacy in patients with ADHF. There have been no trials comparing the efficacy of high-dose oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    to intravenous regimens.",
"   </p>",
"   <p>",
"    Regardless of the regimen, volume status, daily weights, fluid intake and output should be continually assessed. In addition, the patient should be monitored for adverse effects of diuretic therapy such as hypokalemia and hypomagnesemia (which are associated with an increased risk of arrhythmia), a rise in serum creatinine (which is a marker of decreased perfusion to the kidneys), and hypotension. Severe muscle cramps may occur with overly rapid diuresis and should be treated with potassium and magnesium repletion as indicated.",
"   </p>",
"   <p>",
"    We suggest switching from an effective intravenous dose to an oral regimen once the patient&rsquo;s acute symptoms have been stabilized to help ensure that an effective outpatient dose is identified and prescribed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4327964\">",
"    <span class=\"h4\">",
"     Chronic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with fluid overload and chronic HF (and those who have been stabilized following acute decompensation) are generally treated with oral loop diuretics.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who have",
"      <strong>",
"       not",
"      </strong>",
"      received prior loop diuretic therapy:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The usual starting oral dose is 20 to 40 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      or its equivalent once or twice a day. If a patient does not respond to initial dosing, the dose should be increased rather than giving the same dose twice a day. For patients with normal glomerular filtration rate, maximal single oral doses of furosemide are 40 to 80 mg. In patients with renal insufficiency, a higher maximum dose of 160 to 200 mg of furosemide can be given (maximum daily dose of 600 mg).",
"     </li>",
"     <li>",
"      The usual initial oral dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      is 5 to 10 mg with maximum individual dose of 100 mg (maximum daily dose of 200 mg) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The usual initial oral dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      is 0.5 to 1.0 mg with maximum individual dose of 5 mg (maximum daily dose of 10 mg) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dosing in patients who",
"      <strong>",
"       have",
"      </strong>",
"      received prior loop diuretic therapy is based upon the response to prior therapy. The oral dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      is approximately twice the intravenous dose.",
"     </li>",
"     <li>",
"      The dose of diuretic should be adjusted once the patient&rsquo;s dry body weight is attained to the minimum dose required to maintain dry body weight.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intravenous therapy is warranted in patients who do not respond to maximum oral therapy. The regimen is the same as that described above for acute decompensated HF. (See",
"    <a class=\"local\" href=\"#H9160965\">",
"     'Treatment of ADHF'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16979970\">",
"    <span class=\"h3\">",
"     Effects on renal function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The blood urea nitrogen (BUN) and serum creatinine often rise during diuretic treatment of HF and careful monitoring is recommended. In the absence of other causes for an elevated BUN, a disproportionate rise in BUN relative to serum creatinine",
"    <span class=\"nowrap\">",
"     (BUN/serum",
"    </span>",
"    creatinine ratio &gt;20:1) suggests a prerenal state with increased passive reabsorption of urea. An initial rise in BUN may be accompanied by a stable serum creatinine, reflecting preserved glomerular filtration rate (GFR). Further elevations in BUN along with a rise in serum creatinine are likely if diuresis is continued in such patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12138?source=see_link&amp;anchor=H10#H10\">",
"     \"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)\", section on 'Blood urea nitrogen/serum creatinine ratio'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An otherwise unexplained rise in serum creatinine, which reflects a reduction in GFR, may be a marker of reduced perfusion to the kidney and other organs. Patients in whom this occurs before euvolemic status is achieved have a worse prognosis. Nevertheless, fluid removal may still be required to treat signs and symptoms of congestion, particularly pulmonary edema. On the other hand, a stable serum creatinine suggests that perfusion to the kidneys (and therefore to other organs) is being well maintained and that the diuresis can be continued if the patient is still edematous. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35223?source=see_link&amp;anchor=H2022685#H2022685\">",
"     \"Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology\", section on 'Reduced renal perfusion'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44456?source=see_link&amp;anchor=H28486497#H28486497\">",
"     \"Cardiorenal syndrome: Prognosis and treatment\", section on 'Change in GFR during therapy for HF'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Changes in cardiac output and the consequent changes in renal perfusion is not the only determinant of changes in GFR in patients with HF. Among patients with an elevated central venous pressure, the associated increase in renal venous pressure can reduce the GFR, while lowering venous pressure with diuretics and other therapies might therefore increase the GFR. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35223?source=see_link\">",
"     \"Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Guidelines for management of patients with HF with elevated or rising BUN",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serum creatinine include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other potential causes of kidney injury (eg, use of nephrotoxic medications, urinary obstruction) should be evaluated and addressed.",
"     </li>",
"     <li>",
"      Patients with severe symptoms or signs of congestion, particularly pulmonary edema, require continued fluid removal independent of changes in GFR. In the presence of elevated central venous pressure, renal function may improve with diuresis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35223?source=see_link&amp;anchor=H2022699#H2022699\">",
"       \"Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology\", section on 'Increased renal venous pressure'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If the BUN rises and the serum creatinine is stable or increases minimally, and the patient is still fluid overloaded, the diuresis can be continued to achieve the goal of eliminating clinical evidence of fluid retention with careful monitoring of renal function. (See",
"      <a class=\"local\" href=\"#H4016559\">",
"       'Goals of therapy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      If increases in serum creatinine appear to reflect intravascular volume depletion, then reduction in or temporary discontinuation of diuretic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ACE",
"      <span class=\"nowrap\">",
"       inhibitor/ARB",
"      </span>",
"      therapy should be considered. Adjunctive inotropic therapy may be required. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34698?source=see_link&amp;anchor=H19#H19\">",
"       \"Treatment of acute decompensated heart failure: Components of therapy\", section on 'Inotropic agents'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If substantial congestion persists and adequate diuresis cannot be achieved, then ultrafiltration or dialysis should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34698?source=see_link&amp;anchor=H26#H26\">",
"     \"Treatment of acute decompensated heart failure: Components of therapy\", section on 'Ultrafiltration'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/58/25513?source=see_link&amp;anchor=H2#H2\">",
"     \"Renal replacement therapy (dialysis) in acute kidney injury (acute renal failure) in adults: Indications, timing, and dialysis dose\", section on 'Indications for and timing of initiation of dialysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4016559\">",
"    <span class=\"h2\">",
"     Goals of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;As stated in the American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association HF guidelines (last updated in 2009), the goal of diuretic therapy is to eliminate clinical evidence of fluid retention, such as elevated jugular venous pressure and peripheral edema [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"     1",
"    </a>",
"    ]. This goal should be pursued while adverse effects are monitored (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34698?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of acute decompensated heart failure: Components of therapy\", section on 'Monitoring'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrolyte imbalances (particularly hypokalemia and hypomagnesemia) that develop during diuresis should be promptly treated while the diuresis is continued.",
"     </li>",
"     <li>",
"      If hypotension or worsening renal function develops before the goals of treatment are achieved, the diuresis may be slowed. Diuresis should be maintained until fluid retention is eliminated even if this results in asymptomatic mild to moderate decreases in blood pressure or renal function. Excessive concern about hypotension and azotemia can lead to underutilization of diuretics and persistent volume overload. Persistent volume overload contributes to continued symptoms, may reduce the efficacy of drug therapy for HF, and, as suggested in the following study, persistent volume overload may be associated with increased mortality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The potential importance of aggressive fluid removal was suggested by an observational study of 336 patients hospitalized with HF [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/18\">",
"     18",
"    </a>",
"    ]. Patients developing significant hemoconcentration (defined as elevations in at least two of the following three parameters &ndash; hematocrit, serum albumin, and serum total protein) during treatment received higher doses of loop diuretics, lost more weight, and had greater reductions in intracardiac filling pressures. Although hemoconcentration was strongly associated with worsening renal function (odds ratio 5.3), it was also associated with a large and significant reduction in 180 day mortality (adjusted hazard 0.16, 95% CI 0.02 to 0.44).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Time course of the diuresis and associated complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A potential fall in cardiac output induced by loop diuretic therapy (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Filling pressures and cardiac output'",
"    </a>",
"    below) has important implications for the time course of the diuresis. In both normal individuals and those with HF, the ensuing activation of sodium-retaining mechanisms (angiotensin II, aldosterone, and norepinephrine) as well as flow-dependent hypertrophy in the distal tubule limits the response to continued diuretic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, the diuresis and kaliuresis in",
"    <strong>",
"     stable",
"    </strong>",
"    patients with HF are maximal on the first few days (typically with the first dose for sodium excretion) and are complete by two weeks (",
"    <a class=\"graphic graphic_figure graphicRef74940 \" href=\"UTD.htm?15/33/15901\">",
"     figure 2",
"    </a>",
"    ). At this time, continued diuretic therapy will maintain the fluid loss that has been attained but will not induce further fluid or potassium loss unless the dose is increased, a second type of diuretic is added, or there is a change in HF severity or sodium intake. Thus, careful monitoring of serum electrolyte levels is warranted over time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/45/6868?source=see_link\">",
"     \"Time course of loop and thiazide diuretic-induced electrolyte complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of hypokalemia is reduced by concurrent treatment with an aldosterone antagonist. Based on the RALES, EPHESUS and EMPHASIS-HF results, we now recommend aldosterone antagonist in patients who have NYHA class II HF and LVEF &le;30 percent; or NYHA class III to IV HF and an LVEF &lt;35 percent; or are post ST elevation MI with an LVEF &le;40 percent and have either symptomatic heart failure or diabetes mellitus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=see_link&amp;anchor=H15#H15\">",
"     \"Use of aldosterone antagonists in heart failure\", section on 'Our approach'",
"    </a>",
"    .) When used for diuresis or potassium sparing effects, higher doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    may be needed.",
"   </p>",
"   <p>",
"    An aldosterone antagonist (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"     eplerenone",
"    </a>",
"    ) is preferred to a sodium channel blocker (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/12/38085?source=see_link\">",
"     amiloride",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/60/43973?source=see_link\">",
"     triamterene",
"    </a>",
"    ) because of evidence that aldosterone antagonist therapy improves patient outcomes and high levels of aldosterone contribute to cardiovascular disease in patients with HF. In addition, hyperaldosteronism may contribute to diuretic resistance, an effect that can be minimized by aldosterone antagonist therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperkalemia is a potential complication of aldosterone antagonist therapy, particularly in patients who are also treated with an angiotensin inhibitor, who have impaired renal function, or who develop worsening cardiac function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=see_link&amp;anchor=H8#H8\">",
"     \"Use of aldosterone antagonists in heart failure\", section on 'Risk of hyperkalemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once begun, diuretic therapy is generally continued indefinitely for fluid control unless cardiac function improves. However, the diuretic dose should be reconsidered after the patient is placed on other heart failure medications. Daily assessment of patient weight may be the most effective method for documenting effective diuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"     1",
"    </a>",
"    ]. For accurate comparisons, daily measurements should use the same scale and should be performed at the same time each day, usually in the morning, prior to eating and after voiding. Weight comparisons may require adjustment for variations in food intake.",
"   </p>",
"   <p>",
"    Long-term therapy can be facilitated by having the patient record his or her weight each day and allowing him or her to make prespecified changes in dose if the weight increases or decreases beyond a specified range. Increases in body weight of more than 0.9 kg have been associated with an increased risk of heart failure hospitalization; these weight gains typically began at least one week before admission [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a subpopulation of stable patients with less severe HF who can be",
"    <strong>",
"     withdrawn",
"    </strong>",
"    from diuretics. This issue was directly addressed in a 12-week clinical trial of 41 patients with stable HF who had been treated with diuretics but not an ACE inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/25\">",
"     25",
"    </a>",
"    ]. Diuretics were discontinued and the patients randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/58/937?source=see_link\">",
"     lisinopril",
"    </a>",
"    or placebo. The probability of remaining off diuretics at six weeks was 71 percent in patients who had no history of hypertension, had a left ventricular ejection fraction (LVEF) above 27 percent, and had been controlled on a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    dose (or its equivalent) of 40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or less.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     HEMODYNAMIC EFFECTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Filling pressures and cardiac output",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reduction in intracardiac filling pressures induced by fluid removal with diuretics lowers the intravascular pressure, thereby permitting mobilization of edema fluid from the interstitium. Since all capillary beds are involved in patients with marked edema, the edema fluid is mobilized diffusely from the tissues to minimize the reduction in intravascular volume, with a half-life of approximately 20 minutes. The net effect is that systemic hemodynamics are often maintained even with a rapid initial diuresis, although this capacity may be exceeded by a very high rate of diuresis.",
"   </p>",
"   <p>",
"    Despite often marked symptomatic improvement and increased exercise tolerance, the decrease in intracardiac filling pressure induced by the diuresis can, by reducing ventricular preload, lower the cardiac output (by as much as 20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/26\">",
"     26",
"    </a>",
"    ] and increase neuroendocrine activation (eg, higher plasma levels of renin and norepinephrine) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. However, some patients initially have little or no reduction in cardiac output because they are on the flat part of the Frank-Starling curve in which changes in left ventricular end-diastolic pressure have little or no effect on cardiac performance (",
"    <a class=\"graphic graphic_figure graphicRef58693 \" href=\"UTD.htm?32/56/33677\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=see_link&amp;anchor=H6#H6\">",
"     \"Pathophysiology of heart failure: Left ventricular pressure-volume relationships\", section on 'Pressure-volume relationships in heart failure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An otherwise unexplained rise in serum creatinine, which reflects a reduction in glomerular filtration rate (GFR), is a marker of reduced tissue perfusion.",
"   </p>",
"   <p>",
"    A rise in serum creatinine during therapy for HF may occur before euvolemic status is achieved; such patients have a worse prognosis. On the other hand, a stable serum creatinine suggests that perfusion to the kidneys (and therefore to other organs) is being well maintained and that the diuresis can be continued if the patient is still edematous. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35223?source=see_link&amp;anchor=H2022685#H2022685\">",
"     \"Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology\", section on 'Reduced renal perfusion'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44456?source=see_link&amp;anchor=H28486497#H28486497\">",
"     \"Cardiorenal syndrome: Prognosis and treatment\", section on 'Change in GFR during therapy for HF'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, changes in renal perfusion are not the only determinant of changes in GFR in patients with HF. Among critically ill patients with heart failure, the associated increased intra-abdominal pressure (likely associated with an increase in renal venous pressure) can reduce the GFR. Furthermore, lowering initially elevated intra-abdominal pressure with diuretics and other therapies has been associated with an increase in GFR, a relationship not seen with other hemodynamic variables (",
"    <a class=\"graphic graphic_figure graphicRef52087 \" href=\"UTD.htm?15/16/15629\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35223?source=see_link&amp;anchor=H2022699#H2022699\">",
"     \"Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology\", section on 'Increased renal venous pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Venodilatory effect in acute pulmonary edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;When administered to patients with pulmonary edema due to an acute myocardial infarction, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    often induces transient venodilation similar to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    ; the net effect is a fall in cardiac filling pressures and decreased pulmonary congestion prior to the onset of the diuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/31\">",
"     31",
"    </a>",
"    ]. Studies in animals and humans have shown that loop diuretics increase renal and perhaps local production of vasodilator prostaglandins [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/32-35\">",
"     32-35",
"    </a>",
"    ], and that the venodilator response can be prevented by nephrectomy or the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or other nonsteroidal antiinflammatory drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/32-36\">",
"     32-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Vasoconstriction in chronic HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;A deleterious acute hemodynamic response may be seen when a loop diuretic is given intravenously to patients with advanced chronic HF [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/37\">",
"     37",
"    </a>",
"    ]. In this setting, there may be an acute increase in plasma renin and norepinephrine levels, leading to arteriolar vasoconstriction and a rise in systemic blood pressure; this increase in afterload then induces a reduction in cardiac output and a rise in pulmonary capillary wedge pressure with possible worsening of dyspnea. These changes are reversed by one hour, and the filling pressures are reduced by four hours due both to the diuresis and a decrease in vasoconstrictors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/37\">",
"     37",
"    </a>",
"    ]. A similar initial vasoconstrictor response has been demonstrated in patients with cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is uncertain how to reconcile these different hemodynamic effects of diuretic therapy. One possibility is that patients with chronic HF (or cirrhosis) have persistent elevations in renin and angiotensin II release (induced by decreased renal perfusion) that are associated with hyperplasia of the renin secretory apparatus. As a result, administration of a loop diuretic may lead to an exaggerated rise in renin release and systemic vasoconstriction. In comparison, the vasodilator prostaglandin response may predominate in patients with an acute MI who do not have chronic hypersecretion of renin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     REFRACTORY EDEMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with advanced HF become less responsive to conventional oral doses of a loop diuretic due to reductions in renal perfusion and increases in sodium-retaining hormones, such as angiotensin II and aldosterone.",
"   </p>",
"   <p>",
"    Another factor that may contribute to a diminished diuretic response in patients with HF is the presence of hypoalbuminemia. All the commonly used diuretics are highly protein-bound (more than 90 percent). This limits the diuretic to the vascular space, thereby maximizing its rate of delivery to the kidney. The degree of protein-binding is reduced with hypoalbuminemia, resulting in a larger extravascular space of distribution, a slower rate of delivery to the kidney, and possibly reduced diuresis.",
"   </p>",
"   <p>",
"    The approach to treatment of patients with refractory edema is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link\">",
"     \"Treatment of refractory edema in adults\"",
"    </a>",
"    .) Summarized briefly, treatment options in refractory edema include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      is associated with substantial interpatient and intrapatient variability in bioavailability. Thus, patients with an inadequate diuretic response to oral furosemide at the maximum recommended dose may respond to oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      which are more predictably absorbed or to a higher dose of furosemide. (See",
"      <a class=\"local\" href=\"#H9160774\">",
"       'Choice of loop diuretic'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who fail oral therapy may respond to more reliable diuretic delivery via intravenous administration by either intermittent bolus therapy or continuous intravenous infusion. Both methods of delivery appear to have similar efficacy and safety in patients with HF. The efficacy of a continuous intravenous infusion edema has not been evaluated in patients with refractory edema. However, it has not been proven that intravenous diuretic is more effective than high doses of oral therapy. (See",
"      <a class=\"local\" href=\"#H9160965\">",
"       'Treatment of ADHF'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If loop diuretic therapy does not produce a sufficient diuresis, addition of a",
"      <strong>",
"       thiazide-type",
"      </strong>",
"      diuretic may be beneficial by inhibiting sodium reabsorption in the distal tubule. Thiazide efficacy is enhanced in patients chronically treated with a loop diuretic, since the loop diuretic-induced increase in sodium delivery out of the loop of Henle leads to an increase in distal tubule sodium reabsorption (",
"      <a class=\"graphic graphic_figure graphicRef53198 \" href=\"UTD.htm?27/35/28221\">",
"       figure 5",
"      </a>",
"      ). On the other hand, the thiazide-induced increase in sodium delivery out of the distal tubule can increase urinary potassium excretion and reduce the serum potassium concentration. Thus, as with the initiation of loop diuretic therapy or increasing the loop diuretic dose, careful monitoring for the development of hypokalemia is warranted when a thiazide diuretic is added. In patients with stable HF, the increase in urinary potassium excretion at a given dose is greatest in the first week of therapy at a given dose (",
"      <a class=\"graphic graphic_figure graphicRef74940 \" href=\"UTD.htm?15/33/15901\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link&amp;anchor=H18#H18\">",
"       \"Treatment of refractory edema in adults\", section on 'Thiazide plus loop diuretics'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=see_link&amp;anchor=H27627359#H27627359\">",
"       \"Causes of hypokalemia\", section on 'Diuretics'",
"      </a>",
"      .) &nbsp;",
"      <br/>",
"      <br/>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/2/35878?source=see_link\">",
"       Chlorothiazide",
"      </a>",
"      is the only thiazide diuretic that can be given intravenously (500 to 1000",
"      <span class=\"nowrap\">",
"       mg/day).",
"      </span>",
"      However, the availability of this preparation may be limited. An oral thiazide, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8263?source=see_link\">",
"       hydrochlorothiazide",
"      </a>",
"      (25 to 50 mg twice daily),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/14/26854?source=see_link\">",
"       chlorthalidone",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/32/1542?source=see_link\">",
"       metolazone",
"      </a>",
"      (which have the advantage of once daily dosing) is an alternative for acute therapy and can be given chronically.",
"     </li>",
"     <li>",
"      Addition of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"       spironolactone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"       eplerenone",
"      </a>",
"      is recommended in selected patients with systolic HF to improve survival. In addition, the associated reduction in collecting tubule sodium reabsorption and potassium secretion can both enhance the diuresis and minimize the degree of potassium wasting. Thus, if not already being given, it is reasonable to initiate aldosterone antagonist therapy",
"      <strong>",
"       prior",
"      </strong>",
"      to the addition of a thiazide diuretic in patients with a low or low-normal serum potassium on loop diuretic therapy alone.",
"      <br/>",
"      <br/>",
"      Aldosterone antagonist therapy should be continued only in patients who can be carefully monitored for hyperkalemia. These issues are discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=see_link\">",
"       \"Use of aldosterone antagonists in heart failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If these maneuvers are unsuccessful, hemodialysis or hemofiltration can be used for fluid removal. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34698?source=see_link&amp;anchor=H26#H26\">",
"       \"Treatment of acute decompensated heart failure: Components of therapy\", section on 'Ultrafiltration'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=see_link\">",
"       \"Patient information: Heart failure (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The three major manifestations of volume overload in patients with HF are pulmonary congestion, peripheral edema, and elevated jugular venous pressure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link&amp;anchor=H7#H7\">",
"       \"Evaluation of the patient with suspected heart failure\", section on 'Volume assessment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with HF and volume overload, we recommend diuretics (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ) (",
"      <a class=\"graphic graphic_table graphicRef81590 graphicRef70468 \" href=\"UTD.htm?21/29/21982\">",
"       table 1A-B",
"      </a>",
"      ). Such patients should also restrict dietary sodium. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diuretic use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The absorption of oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      is approximately 50 percent with wide interpatient and intrapatient variability. This is in contrast to oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      , which are more predictably absorbed. (See",
"      <a class=\"local\" href=\"#H9160774\">",
"       'Choice of loop diuretic'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intravenous diuretics (either as a bolus or a continuous infusion) are more potent than equivalent oral doses, and are sometimes required for unstable or severe disease. (See",
"      <a class=\"local\" href=\"#H9160965\">",
"       'Treatment of ADHF'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The usual initial intravenous bolus dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      is 20 to 40 mg or up to 2.5 times the previously ineffective oral dose; if no response is obtained, the dose may be repeated every two hours with doubling of the dose as needed up to maximum doses. In patients with a normal glomerular filtration rate (typically estimated from the serum creatinine concentration), the maximum intravenous doses are usually 40 to 80 mg of furosemide, 20 to 40 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      , or 1 to 2 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      . However, at times higher doses are needed.",
"     </li>",
"     <li>",
"      Patients with renal insufficiency require higher maximum bolus doses of up to 160 to 200 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      , 100 to 200 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      , or 4 to 8 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link&amp;anchor=H3#H3\">",
"       \"Treatment of refractory edema in adults\", section on 'Basic principles of diuretic dosing'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link&amp;anchor=H12#H12\">",
"       \"Treatment of refractory edema in adults\", section on 'Maximum effective dose of loop diuretics'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with more chronic HF, the usual starting oral dose is 20 to 40 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      . If a patient does not respond to initial dosing, the dose should be increased rather than giving the same dose twice a day. (See",
"      <a class=\"local\" href=\"#H4327964\">",
"       'Chronic therapy'",
"      </a>",
"      above.) If there is a good, but short, response, more frequent dosing may be needed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Maximal single oral doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      are 40 to 80 mg for patients with a normal glomerular filtration rate. In patients with renal insufficiency, a higher maximum dose of 160 to 200 mg of furosemide can be given (maximum daily dose of 600 mg).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       Torsemide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      are more predictably absorbed than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      . The usual initial oral dose of torsemide is 5 to 10 mg with maximum individual dose of 100 mg (maximum daily dose of 200 mg). The usual initial oral dose of bumetanide is 0.5 to 1.0 mg with maximum individual dose of 5 mg (maximum daily dose of 10 mg) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The goal of diuretic therapy is to eliminate clinical evidence of fluid retention, such as elevated jugular venous pressure and peripheral edema. This goal should be pursued while adverse effects are monitored. Persistent volume overload contributes to continued symptoms, may reduce the efficacy of drug therapy for HF, and may be associated with increased mortality. (See",
"      <a class=\"local\" href=\"#H4016559\">",
"       'Goals of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In stable patients on a stable diuretic regimen, the fluid and electrolyte complications of diuretic therapy (eg, volume depletion, hypokalemia with loop diuretics, and hyperkalemia with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"       spironolactone",
"      </a>",
"      ) are complete at two to three weeks. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Time course of the diuresis and associated complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diuresis causes clinically beneficial reductions in cardiac filling pressures in terms of fluid overload but may lead to a decline in cardiac output, particularly in overdiuresed patients. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Filling pressures and cardiac output'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Options for patients with refractory edema following oral or intravenous diuretic therapy include switching to a more reliably absorbed oral loop diuretic (ie,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/13/28886?source=see_link\">",
"       torsemide",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/9/43158?source=see_link\">",
"       bumetanide",
"      </a>",
"      in place of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      ), use of high doses of oral furosemide, continuous intravenous infusion of a loop diuretic (which is of uncertain benefit), addition of a thiazide-type diuretic, and, if not already prescribed, the administration of an aldosterone antagonist (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"       spironolactone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"       eplerenone",
"      </a>",
"      ), which also increases the serum potassium concentration and has been demonstrated to improve cardiovascular outcomes in selected patients. If attempts at diuresis are unsuccessful, hemofiltration can be used for fluid removal. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Refractory edema'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/1\">",
"      Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:e391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/2\">",
"      Faris R, Flather MD, Purcell H, et al. Diuretics for heart failure. Cochrane Database Syst Rev 2006; :CD003838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/3\">",
"      Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/4\">",
"      Felker GM, O'Connor CM, Braunwald E, Heart Failure Clinical Research Network Investigators. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2009; 2:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/5\">",
"      Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/6\">",
"      Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010; 16:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/7\">",
"      Brater DC. Diuretic therapy. N Engl J Med 1998; 339:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/8\">",
"      Vargo DL, Kramer WG, Black PK, et al. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 1995; 57:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/9\">",
"      Murray MD, Deer MM, Ferguson JA, et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 2001; 111:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/10\">",
"      M&uuml;ller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life. Eur J Heart Fail 2003; 5:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/11\">",
"      Wargo KA, Banta WM. A comprehensive review of the loop diuretics: should furosemide be first line? Ann Pharmacother 2009; 43:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/12\">",
"      Young M, Plosker GL. Torasemide: a pharmacoeconomic review of its use in chronic heart failure. Pharmacoeconomics 2001; 19:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/13\">",
"      Cos&iacute;n J, D&iacute;ez J, TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail 2002; 4:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/14\">",
"      Brater DC, Day B, Burdette A, Anderson S. Bumetanide and furosemide in heart failure. Kidney Int 1984; 26:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/15\">",
"      Brater DC. Update in diuretic therapy: clinical pharmacology. Semin Nephrol 2011; 31:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/16\">",
"      Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005; :CD003178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/17\">",
"      Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010; 16:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/18\">",
"      Testani JM, Chen J, McCauley BD, et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/19\">",
"      Bock HA, Stein JH. Diuretics and the control of extracellular fluid volume: role of counterregulation. Semin Nephrol 1988; 8:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/20\">",
"      Ikram H, Chan W, Espiner EA, Nicholls MG. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci (Lond) 1980; 59:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/21\">",
"      Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/22\">",
"      Schrier RW. Use of diuretics in heart failure and cirrhosis. Semin Nephrol 2011; 31:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/23\">",
"      Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007; 116:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/24\">",
"      Wolfel EE. Can we predict and prevent the onset of acute decompensated heart failure? Circulation 2007; 116:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/25\">",
"      Grinstead WC, Francis MJ, Marks GF, et al. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 73:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/26\">",
"      Stampfer M, Epstein SE, Beiser GD, Braunwald E. Hemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function. Circulation 1968; 37:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/27\">",
"      Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990; 82:1724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/28\">",
"      Wang DJ, Gottlieb SS. Diuretics: still the mainstay of treatment. Crit Care Med 2008; 36:S89.",
"     </a>",
"    </li>",
"    <li>",
"     Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.504.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/30\">",
"      Mullens W, Abrahams Z, Skouri HN, et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 2008; 51:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/31\">",
"      Dikshit K, Vyden JK, Forrester JS, et al. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 1973; 288:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/32\">",
"      Bourland WA, Day DK, Williamson HE. The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. J Pharmacol Exp Ther 1977; 202:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/33\">",
"      Johnston GD, Hiatt WR, Nies AS, et al. Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res 1983; 53:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/34\">",
"      Fujimura A, Ebihara A. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration. Hypertension 1988; 11:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/35\">",
"      Pickkers P, Dormans TP, Russel FG, et al. Direct vascular effects of furosemide in humans. Circulation 1997; 96:1847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/36\">",
"      Jhund PS, Davie AP, McMurray JJ. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. J Am Coll Cardiol 2001; 37:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/37\">",
"      Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985; 103:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/55/3962/abstract/38\">",
"      Daskalopoulos G, Laffi G, Morgan T, et al. Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. Gastroenterology 1987; 92:1859.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3512 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-8B216F4EAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3962=[""].join("\n");
var outline_f3_55_3962=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31397796\">",
"      EFFICACY AND SAFETY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1507026889\">",
"      Salt and water restriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Diuretic use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9160724\">",
"      Use of loop diuretics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9160774\">",
"      - Choice of loop diuretic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Loop diuretic dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9160965\">",
"      Treatment of ADHF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4327964\">",
"      Chronic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16979970\">",
"      - Effects on renal function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4016559\">",
"      Goals of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Time course of the diuresis and associated complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      HEMODYNAMIC EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Filling pressures and cardiac output",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Venodilatory effect in acute pulmonary edema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Vasoconstriction in chronic HF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      REFRACTORY EDEMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/3512\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3512|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/36/16973\" title=\"figure 1\">",
"      Loop diuretic dose response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/33/15901\" title=\"figure 2\">",
"      Time course of diuretic action",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/56/33677\" title=\"figure 3\">",
"      Frank Starling curves in HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/16/15629\" title=\"figure 4\">",
"      Change in sCr versus change in IAP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/35/28221\" title=\"figure 5\">",
"      Distal response to furosemide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3512|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/1/40989\" title=\"table 1A\">",
"      ACC AHA Rx systolic HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/7/8316\" title=\"table 1B\">",
"      ACC AHA Rx HF normal LVEF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/2/3117\" title=\"table 2\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35223?source=related_link\">",
"      Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44456?source=related_link\">",
"      Cardiorenal syndrome: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=related_link\">",
"      Causes of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/3/42039?source=related_link\">",
"      Drugs that should be avoided or used with caution in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12138?source=related_link\">",
"      Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7544?source=related_link\">",
"      Evaluation of acute decompensated heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=related_link\">",
"      Evaluation of the patient with suspected heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38742?source=related_link\">",
"      Hyponatremia in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/48/40710?source=related_link\">",
"      Loop diuretics: Maximum effective dose and major side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/4/24648?source=related_link\">",
"      Nonselective NSAIDs: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=related_link\">",
"      Pathophysiology of heart failure: Left ventricular pressure-volume relationships",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32455?source=related_link\">",
"      Pathophysiology of heart failure: Neurohumoral adaptations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=related_link\">",
"      Patient information: Heart failure (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/58/25513?source=related_link\">",
"      Renal replacement therapy (dialysis) in acute kidney injury (acute renal failure) in adults: Indications, timing, and dialysis dose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/45/6868?source=related_link\">",
"      Time course of loop and thiazide diuretic-induced electrolyte complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7018?source=related_link\">",
"      Treatment and prognosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34698?source=related_link\">",
"      Treatment of acute decompensated heart failure: Components of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41079?source=related_link\">",
"      Treatment of acute decompensated heart failure: General considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=related_link\">",
"      Treatment of refractory edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28521?source=related_link\">",
"      Use of aldosterone antagonists in heart failure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_55_3963="Retinal dis and photopsias";
var content_f3_55_3963=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F82416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F82416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Retinal pathologies associated with elementary visual hallucinations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Posterior vitreous detachment with retinal traction or retinal tear",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Retinal detachment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cone dystrophies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cancer-associated retinopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Melanoma-associated retinopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmune-associated retinopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute zonal occult outer retinopathies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other pathology causing mechanical changes in retina",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3963=[""].join("\n");
var outline_f3_55_3963=null;
var title_f3_55_3964="Indications pacing modes I";
var content_f3_55_3964=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for different pacing modes - I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Mode",
"       </td>",
"       <td class=\"subtitle1\">",
"        Generally agreed upon indications",
"       </td>",
"       <td class=\"subtitle1\">",
"        Controversial indications",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contraindicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VVI",
"       </td>",
"       <td>",
"        Atrial fibrillation with symptomatic bradycardia in the chronotropically competent patient",
"       </td>",
"       <td>",
"        Symptomatic bradycardia in the patient with associated terminal illness or other medical conditions from which recovery is not anticipated and pacing is life-sustaining only",
"       </td>",
"       <td>",
"        <p>",
"         Patients with known pacemaker syndrome or hemodynamic deterioration with ventricular pacing at the time of implant",
"        </p>",
"        <p>",
"         Chronotropic incompetent patient who will benefit from rate response",
"        </p>",
"        <p>",
"         Patients with hemodynamic need for dual-chamber pacing",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VVIR",
"       </td>",
"       <td>",
"        Fixed atrial arrhythmias (atrial fibrillation or flutter) with symptomatic bradycardia in the chronotropically incompetent patient",
"       </td>",
"       <td>",
"        As for VVI",
"       </td>",
"       <td>",
"        As for VVI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AAI",
"       </td>",
"       <td>",
"        Symptomatic bradycardia as a result of sinus node dysfunction in the otherwise chronotropically competent patient and when AV conduction can be proven normal",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Sinus node dysfunction with associated AV block either demonstrated spontaneously or during pre-implant testing",
"        </p>",
"        <p>",
"         When adequate atrial sensing cannot be attained",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AAIR",
"       </td>",
"       <td>",
"        Symptomatic bradycardia as a result of sinus node dysfunction in the otherwise chronotropically incompetent patient and when AV conduction can be proven normal",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        As for AAI",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3964=[""].join("\n");
var outline_f3_55_3964=null;
var title_f3_55_3965="Rand trials marg width melanoma";
var content_f3_55_3965=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Randomized trials examining optimal surgical margin width for cutaneous melanoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study, author; year",
"       </td>",
"       <td class=\"subtitle1\">",
"        n",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median follow-up",
"       </td>",
"       <td class=\"subtitle1\">",
"        Melanoma thickness",
"       </td>",
"       <td class=\"subtitle1\">",
"        Margins",
"       </td>",
"       <td class=\"subtitle1\">",
"        Local recurrence, (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Overall survival, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        <p>",
"         World Health Organization",
"        </p>",
"        <p>",
"         Cascinelli, N; 1998",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        612",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        12 yrs",
"       </td>",
"       <td>",
"        0-1 mm",
"       </td>",
"       <td>",
"        1 cm",
"       </td>",
"       <td>",
"        3/186 (1.6)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        87",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1.1-2 mm",
"       </td>",
"       <td>",
"        1 cm",
"       </td>",
"       <td>",
"        5/119 (4.2)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0-1 mm",
"       </td>",
"       <td>",
"        3 cm",
"       </td>",
"       <td>",
"        1/173 (0.6)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        85",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1.1-2 mm",
"       </td>",
"       <td>",
"        3 cm",
"       </td>",
"       <td>",
"        2/134 (1.5)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        <p>",
"         Swedish",
"        </p>",
"        <p>",
"         Cohn-Cedarmark, G; 2000",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        989",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        11 yrs",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        0.8-2 mm",
"       </td>",
"       <td>",
"        2 cm",
"       </td>",
"       <td>",
"        3/476 (0.6)",
"       </td>",
"       <td>",
"        79",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5 cm",
"       </td>",
"       <td>",
"        5/513 (1)",
"       </td>",
"       <td>",
"        76",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        <p>",
"         French Cooperative Group",
"        </p>",
"        <p>",
"         Khayat, D; 2003",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        326",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        16 yrs",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        &lt;2.1 mm",
"       </td>",
"       <td>",
"        2 cm",
"       </td>",
"       <td>",
"        1/181 (0.05)",
"       </td>",
"       <td>",
"        87",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5 cm",
"       </td>",
"       <td>",
"        4/185 (0.2)",
"       </td>",
"       <td>",
"        86",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        <p>",
"         Melanoma Intergroup Trial",
"        </p>",
"        <p>",
"         Karakoussis, CP; 1996",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        468",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        8 yrs",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        1-4 mm",
"       </td>",
"       <td>",
"        2 cm",
"       </td>",
"       <td>",
"        (2.1)",
"       </td>",
"       <td>",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4 cm",
"       </td>",
"       <td>",
"        (2.6)",
"       </td>",
"       <td>",
"        84",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        <p>",
"         British Trial",
"        </p>",
"        <p>",
"         Thomas, JM; 2004",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        900",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        60 mos",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        &ge;2 mm",
"       </td>",
"       <td>",
"        1 cm",
"       </td>",
"       <td>",
"        15/453 (3.3)",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        No significant difference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 cm",
"       </td>",
"       <td>",
"        13/457 (2.8)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3965=[""].join("\n");
var outline_f3_55_3965=null;
var title_f3_55_3966="Chronic versus acute tamponade";
var content_f3_55_3966=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 503px\">",
"   <div class=\"ttl\">",
"    Pericardial pressure in acute and chronic tamponade",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 483px; height: 344px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Volume curves recorded from data acquired during pericardiocentesis. Curve A (in red) plots data from a patient with hyperacute tamponade that followed laceration of a coronary artery during an angioplasty-stenting procedure. Note the extreme elevation of pericardial pressure and that withdrawal of only 100 mL, half the volume we could aspirate, lowered the pressure to 10 mmHg. Curve B (in blue) plots data from a patient who had a history of prior pericarditis, assumed to be of viral etiology. Subsequently he developed a chronic pericardial effusion that reached at least 1500 mL in volume. At the time of presentation to our service, the jugular venous pressure was 22 mmHg. Aspiration of 300 mL of pericardial fluid reduced the pericardial pressure to 10 mmHg, and removing another 600 mL achieved a nearly normal pericardial pressure. Aspiration of the remaining large effusion did not affect pericardial pressure. The curves of cases of intermediate acuity or chronicity would fall between these two extremes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ralph Shabetai, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3966=[""].join("\n");
var outline_f3_55_3966=null;
var title_f3_55_3967="Left main coronary disease";
var content_f3_55_3967=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/70747/lfmaincd_conv.mp4?title=Left+main+coronary+disease\" style=\"width:288px;height:272px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left main coronary disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 289px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left main coronary artery has a severe narrowing at its beginning, ie, the ostium. The two major branches of the left main, the left anterior descending artery (top) and the circumflex artery (bottom) are also severely diseased. The presence of sternal wires and surgical clips indicate that this individual has already undergone a coronary bypass operation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John D Carroll, MD. This type of movie will be part of The Multimedia Textbook of Coronary Arteriography and Interventions, Williams &amp; Wilkins, Baltimore, Fall, 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_55_3967=[""].join("\n");
var outline_f3_55_3967=null;
